<SEC-DOCUMENT>0001683168-23-005434.txt : 20230809
<SEC-HEADER>0001683168-23-005434.hdr.sgml : 20230809
<ACCEPTANCE-DATETIME>20230809075334
ACCESSION NUMBER:		0001683168-23-005434
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20230804
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230809
DATE AS OF CHANGE:		20230809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		231153414

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>radnet_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:RDNT="http://radnet.com/20230804">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_RDNT_radnet.com_20230804 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20230804_20230804 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000790526 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:EntityCentralIndexKey">0000790526</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rdnt-20230804.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-08-04to2023-08-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-04</xbrli:startDate>
        <xbrli:endDate>2023-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">UNITED
STATES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Washington,
D.C. 20549</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>FORM
<span id="xdx_908_edei--DocumentType_c20230804__20230804_zEVCA3ENdiSa"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Date
of Report (Date of earliest event reported) <b><span id="xdx_90A_edei--DocumentPeriodEndDate_c20230804__20230804_znq1C1gfFNbb"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August
4, 2023</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">_______________________________________________</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_902_edei--EntityRegistrantName_c20230804__20230804_zcsDEgf4Ad64" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:EntityRegistrantName">RadNet,
Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center; padding-left: 10pt; width: 32%"><b><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20230804__20230804_zid2a2HUHxe2" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; padding-left: 10pt; width: 32%"><span id="xdx_90D_edei--EntityFileNumber_c20230804__20230804_zmiFSLEkCqL4" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:EntityFileNumber">001-33307</ix:nonNumeric></b></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 32%"><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20230804__20230804_zqMw3KN1Cnu5" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:EntityTaxIdentificationNumber">13-3326724</ix:nonNumeric></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">(State or other jurisdiction<br />
    of incorporation)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(IRS Employer Identification No.)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.9pt; text-indent: -16.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.9pt; text-indent: -16.75pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; width: 49%"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20230804__20230804_z90g3h2FMTK2"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:EntityAddressAddressLine1">1510 Cotner Avenue</ix:nonNumeric></span></b></td>
  <td style="width: 2%">&#160;</td>
  <td style="text-align: center; width: 49%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1pt solid; text-align: center"><b><span id="xdx_907_edei--EntityAddressCityOrTown_c20230804__20230804_zrWDupjwJ0pb"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:EntityAddressCityOrTown">Los
  Angeles</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20230804__20230804_zJ5GbAf43L47"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: center"><b><span id="xdx_901_edei--EntityAddressPostalZipCode_c20230804__20230804_ziaw0AcAhAj8"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:EntityAddressPostalZipCode">90025</ix:nonNumeric></span></b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center">(Address of Principal Executive Offices)</td>
  <td>&#160;</td>
  <td style="text-align: center">(Zip Code)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.9pt; text-indent: -16.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Registrant&#8217;s
Telephone Number, Including Area Code: <b>(<span id="xdx_90A_edei--CityAreaCode_c20230804__20230804_zOfwSXt7TuJk"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:CityAreaCode">310</ix:nonNumeric></span>) <span id="xdx_904_edei--LocalPhoneNumber_c20230804__20230804_zDRJDIbfGye4"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:LocalPhoneNumber">478-7808</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">(Former name or former
address, if changed since last report.)</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_909_edei--WrittenCommunications_c20230804__20230804_zDUPrg6qXaO2" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Written
                                            communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_907_edei--SolicitingMaterial_c20230804__20230804_zTl0zHvU0Ew1" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Soliciting
                                            material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_909_edei--PreCommencementTenderOffer_c20230804__20230804_zwnwvRWU1pRl" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Pre-commencement
                                            communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20230804__20230804_zFYnB7zLreb9" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Pre-commencement
                                            communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 35%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
                                            of each class</b></span></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
<tr>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span id="xdx_908_edei--Security12bTitle_c20230804__20230804_zL72QGcwZKl5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:Security12bTitle">Common
    Stock, $0.0001 par value</ix:nonNumeric></span></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span id="xdx_909_edei--TradingSymbol_c20230804__20230804_z2mlngc2xRcf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" name="dei:TradingSymbol">RDNT</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span id="xdx_900_edei--SecurityExchangeName_c20230804__20230804_z8xCJMFo6Sy3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ
    Global Market</ix:nonNumeric></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company <span id="xdx_900_edei--EntityEmergingGrowthCompany_c20230804__20230804_zajaqzCNrMNe"><ix:nonNumeric contextRef="From2023-08-04to2023-08-04" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 2.02</b></td><td><b>Results of Operations and Financial Condition </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 8, 2023 RadNet, Inc. (the &#8220;Company&#8221;)
issued a press release and held a conference call regarding its 2023 financial results for the second quarter ended June 30, 2023. A copy
of the press release is furnished as Exhibit 99.1 and a copy of the transcript of the conference call is furnished as Exhibit 99.2 to
this Current Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information in this Item 2.02, including Exhibit
99.1 and Exhibit 99.2 is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Item 2.02, including Exhibit 99.1 and Exhibit
99.2 shall not be incorporated by reference into any registration statement or other document filed with the Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 5.02</b></td><td><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.95pt 0pt 8.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 4, 2023, the Company appointed Dr. Gregory
Sorensen, M.D. (&#8220;Dr. Sorensen&#8221;) to the Board of Directors (the &#8220;Board&#8221;) and to serve as the Company&#8217;s Executive
Vice President and Chief Science Officer, with such appointment effective August 8, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From 2017 to the present, Dr. Sorensen, age
61, has served as the Chief Executive Officer of DeepHealth, Inc. (&#8220;DeepHealth&#8221;), a subsidiary of the Company that is
focused on using artificial intelligence and deep learning methods to advance medical care with a special emphasis on breast cancer
imaging. The Company acquired DeepHealth in June 2020. Dr. Sorensen served as the President and Chief Executive Officer of Siemens
Healthcare North America from 2011 to 2015. Prior to that, he served as a Professor at Harvard Medical School and as a
neuroradiologist at Massachusetts General Hospital, where he worked from 1990 to 2011. <span style="background-color: white">Dr.
Sorensen currently serves as: the Executive Chairman of the board of directors of IMRIS, Deerfield Imaging, Inc., which is focused
on the integration of imaging technologies in a neurosurgical setting; a Board member for RealmIDX, Inc., an integrated diagnostics
company wholly owned by KonicaMinolta; and a member of the Supervisory Board for Fresenius Medical Care AG &amp; Co KGaA, a provider of products and
services for people with chronic kidney failure. Dr. Sorensen served as a Supervisory Board Member at Siemens Healthineers from 2018
to 2023. Dr. Sorensen holds a B.S. in biology from the California Institute of Technology, an M.S. in computer science from Brigham
Young University, and an M.D. degree from Harvard Medical School.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Sorensen entered into an Employment Agreement
with RadNet Management, Inc., a Delaware corporation and wholly owned subsidiary of the Company on June 1, 2020. The Employment Agreement
provides for an annual base salary of $600,000 and an annual restricted stock grant (&#8220;Restricted Stock Award&#8221;), pursuant to
the Company&#8217;s Equity Incentive Plan, determined by dividing his Base Salary per calendar year by the grant price of such shares
as determined by the board of directors of RadNet Management on the date of each grant. Subject to Dr. Sorensen&#8217;s continuous service,
the annual award under his Employment Agreement incrementally vests by one third (1/3) on each of the three successive annual anniversaries
of the Restricted Stock Award grant date. Since the beginning of the Company&#8217;s last fiscal year, Dr. Sorensen received a Restricted
Stock Awards under his Employment Agreement for 29,240 and 20,155 shares of restricted stock in June 2022 and 2023, respectively, as well
as an Restricted Stock Award for 31,579 shares or restricted stock in January 2023, each subject to continuous service with the Company
and the other terms of the Equity Incentive Plan and his award agreement. If the Company terminates Dr. Sorensen&#8217;s employment without
&#8220;Cause&#8221; or Dr. Sorensen resigns for &#8220;Good Reason&#8221; (each as defined in the Employment Agreement), then Dr. Sorensen
is entitled to receive a severance payment equal to 12 months of his base salary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.95pt 0pt 8.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary description of the Employment
Agreement is not complete and is subject to and qualified in its entirety by the terms of the Employment Agreement, which is filed herewith
as Exhibit 10.1 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 34pt">(d)<b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</b>Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Exhibit Number</span></b></span></td>
    <td style="width: 85%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Description of Exhibit</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="radnet_ex1001.htm">Employment Agreement between RadNet Management, Inc. and Gregory Sorensen, M.D., entered into on June 1, 2020.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="radnet_ex9901.htm">Press Release dated August 8, 2023 relating to RadNet, Inc.&#8217;s financial results for the second quarter ended June 30, 2023.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td><a href="radnet_ex9902.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transcript of conference call.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b></b></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><b></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 99.1pt 0 98.85pt; text-align: center; background-color: white"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: August 9, 2023</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RadNet, Inc.</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 53%">&#160;</td>
    <td style="width: 6%">&#160;</td>
    <td style="width: 39%; text-align: center">&#160;</td>
    <td style="width: 2%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mark D. Stolper</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark D. Stolper</span></td>
    <td>&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer </span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LdpNBbdLh4o4ZYwh3hYXpbg1I61/j+Rb2m2IIRCSc74cIUZiQ2tdI8NpWWRQYtPWyiEUeEFGc0bvSLe7BPws8KqtY2Vcv/7AlDyDnpmPY+XvvfOhLVYJyMVExpMoBDlL5BTyvQg6PSVz0RUap1UNylSQM7Ws0Sl+Dx9K9SJDzbtPOiJbTSaBcCwH+QORDCM40EM9iW8WsiwVwaivQGyY7m0Xc7eOGljV2PgsO6D/Dr7iWkkg -->

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>radnet_ex1001.htm
<DESCRIPTION>EMPLOYMENT AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.9pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Employment
Agreement (&quot;Agreement&quot;) is entered into as of June 1, 2020, by and between <B>RADNET MANAGEMENT, INC., </B>a Delaware corporation
(the &quot;Company&quot;), and <B>Gregory Sorensen, M.D. </B>(the &quot;Employee&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration
of the mutual covenants and conditions set forth herein, and other good and valuable consideration, the parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Employment.</U> The Company hereby agrees to employ Employee in the capacity of Senior Vice President of the Company and President
of the Company's subsidiary, DeepHealth, Inc. Employee accepts such employment and agrees to perform such services as are customary to
such offices and as shall from time to time be assigned to him by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Term.</U> Employee's employment hereunder shall commence on June 1, 2020 (the &quot;Commencement Date&quot;) and shall continue
for a period of five (5) years thereafter unless earlier terminated as provided in Section 5 (the &quot;Term&quot;). Employee's employment
will be on a full-time basis requiring the devotion of such amount of his professional time as is necessary for the efficient operation
of the business of the Company. Notwithstanding the above, employee shall be permitted to hold directorships in companies not in competition
with RadNet Management, Inc., and/or positions with charitable organizations, trusts, passive business interests and personal investments,
provided that doing so does not create a conflict of interest, and as long as such services are not provided to any competitor of the
Company and do not materially interfere with Employee's performance of services to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: left"><U>Compensation and Benefits.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Salary</U>. For the performance of Employee's duties hereunder, the Company shall pay Employee an annual salary of Six Hundred
Thousand Dollars ($600,000) (&quot;Base Compensation&quot;), payable (after deducting required withholdings) in accordance with the Company's
ordinary payroll practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Annual Stock Grant</U>. Subject to the approval of the Compensation Committee of the Board of Directors of RadNet, Inc., a Delaware
corporation, which is the Company's parent entity (&quot;RNI&quot;), Employee shall receive a grant each calendar year during the initial
Term equal to that number of restricted common shares of RNI (&quot;RS Award&quot;) under RNI'S 2006 Equity Incentive Plan as amended
(&quot;Plan&quot;), determined by dividing Six Hundred Thousand Dollars ($600,000) per calendar year by the grant price of such shares
as determined by the Board of Directors of RNI on the date of each grant. Subject to Employee's continuous service, one third (1/3rd)
of the RS Award shall incrementally vest on each of the three successive annual anniversaries of the RS Award grant date. The RS Award
shall be governed by the Plan and the RS Award grant agreement which Employee must timely execute as a condition of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 8.6pt; text-align: justify; text-indent: 70.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Benefits.</U> Employee shall be entitled to such medical, disability and life insurance coverage and such sick leave and holiday
benefits, if any, and any other benefits as are made available to the Company's corporate officers, all in accordance with the Company's
benefits policies and programs in effect from time to time and to be mutually agreed upon by Employee. Employee will accrue paid vacation
on a pro-rata basis, in an amount equivalent to six (6) weeks per year, subject to any and all accrual caps and rules and procedures established
by Company policy regarding the use and accrual of vacation. Employee shall also be covered by the Company's Directors and Officers insurance
coverage during Employee's employment with the Company, as well as such other insurance coverage as the Company approves and/or is required
by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reimbursement of Expenses.</U> Employee shall be entitled to be reimbursed for all reasonable and necessary expenses, including
but not limited to expenses for travel, meals and entertainment, incurred by Employee in connection with and reasonably related to the
furtherance of the Company's business; provided, however, that the Company requires as a condition to such reimbursements, that Employee
comply with the Company's expense reimbursement policies. Reasonable and necessary telephone and internet expenses will be reimbursed
in accordance with Company policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Annual Review.</U> The Company's Board of Directors (or, if delegated by the Board of Directors, the Company's Compensation
Committee or Chief Executive Officer) will, on an annual basis, review Employee's performance and compensation hereunder (including salary,
bonus and stock options and/or other equity incentives).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: left"><U>Change in Control.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event of a Change in Control of RNI (as defined below), all options, warrants and any other deferred equity compensation
then granted to Employee by RNI which are unvested at the date of the Change in Control will vest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Definition.</U> As used herein, a &quot;Change in Control&quot; has the same meaning provided to it in the 2006 Equity Incentive
Plan as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: left"><U>Termination.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination Events.</U> Employee's employment hereunder will terminate upon the occurrence of any of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: left">Employee dies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company, by written notice to Employee or his personal representative, discharges Employee due to Employee's Disability (as
defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 13.55pt 0pt 8.25pt; text-align: justify; text-indent: 139.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">As
used in this Agreement, the term &quot;Disability&quot; shall mean that for a period of at least 120 days during any twelve consecutive
month period on account of a mental or physical condition, Employee is unable to perform the essential functions of his job for the Company,
with or without reasonable accommodation. The determination of Employee's Disability shall be made (a) by a medical physician selected
or agreed to by the Company or (b) upon mutual agreement of the Company and Employee or his personal representative. All costs relating
to the determination of whether Employee has incurred a Disability shall be paid by the Company. Employee shall submit to any examination
that is reasonably required by an examining physician for purposes of determining whether a Disability exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: left">Employee is discharged by the Company for Cause (as defined below):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">As used in this Agreement, the term &quot;Cause&quot;
shall mean:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Employee's conviction of (or plea of guilty or <I>nolo contendere </I>to) (A) any felony or (B) any misdemeanor involving fraud
or dishonesty in connection with the performance of his duties hereunder or moral turpitude; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the willful and continued failure of Employee for a total of 10 days (which need not be consecutive days) within any fiscal year
of the Company to substantially perform his duties with the Company (other than any such failure resulting from illness or Disability)
after a written demand for substantial performance from the Company is delivered to Employee, which demand specifically identifies the
manner in which it is claimed Employee has not substantially performed his duties, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Employee has willfully engaged in misconduct which has, or can reasonably be expected to have, a direct and material adverse monetary
effect on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">For purposes
of this Section, no act or failure to act on Employee's part shall be considered &quot;willful&quot; unless Employee acted in bad faith
or without a reasonable belief that Employee's action or omission was in the best interest of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Employee is discharged by the Company for any reason, other than for Cause or Disability, which the Company may do at any time.
For the avoidance of doubt, a Change in Control, on its own, shall not constitute a termination, even if Employee's employer changes as
a result of such Change in Control;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Employee voluntarily terminates his employment due to either (i) a material default by the Company in the performance of any of
its obligations hereunder, or (ii) an Adverse Change in Duties (as defined below), which default or Adverse Change in Duties remains
unremedied by the Company for a period of thirty days following its receipt of written notice thereof from Employee (which notice must
be provided to the Company within 45 days of the initial existence of the applicable event and which reasonably describes the facts claimed
by Employee to constitute the default or Adverse Change in Duties) (the reasons described in items (i) and (ii) of this paragraph being
referred to herein as &quot;Good Reason&quot;) and such Good Reason termination is consummated by Employee within 30 business days after
the expiration of the Company's 30 day remedy period; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Employee voluntarily terminates his employment for any reason other than Good Reason, which Employee may do at any time with at
least 30 days' advance notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">As used
in this Agreement, &quot;Adverse Change in Duties&quot; means an action or series of actions taken by the Company and/or the Board of
Directors of the Company, without Employee's prior written consent, which results in:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A change in Employee's reporting structure, titles, job duties or job functions which results in a material diminution of his status,
control, authority or level of responsibility; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The assignment to Employee of any positions, duties or responsibilities which are materially inconsistent with Employee's positions,
duties and responsibilities or status with the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A requirement by the Company that Employee be based or perform his duties anywhere other than (i) where they are currently performed
(or within a 25 mile radius of that location), or (ii) at the Company's corporate office location on the date of this Agreement; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: left">A reduction by the Company in Employee's Base Compensation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">5.2.</TD><TD STYLE="text-align: left"><U>Effects of Termination.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon termination of Employee's employment hereunder for any reason, the Company will promptly pay Employee all compensation owed
to Employee and unpaid through the effective date of termination (including without limitation Base Compensation and Employee's properly
documented expense reimbursements).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In addition, if Employee's employment is terminated under Sections 5.1 (d) or (e) during the Term, and there has been a Change
in Control within twelve (12) months prior to the termination, provided that Employee signs and does not revoke a complete and general
release of claims in a form to be reasonably determined by the Company, and is in material compliance with this Agreement, then the Company
shall also pay Employee, not later than the fifteenth day after the effective date of the release, a lump sum severance payment in an
amount equal to twelve (12) months of Base Compensation (&quot;Severance
Pay&quot;). If there has not been a Change in Control with the previous twelve months of the termination date, Employee shall receive
the Severance Pay in substantially equal installments over the twelve month (12) month period following the termination date with the
first installment commencing with the fifteenth day after the effective date the release and the last installment occurring on the second
anniversary of the termination date. Notwithstanding the foregoing, with respect to the Severance Pay, (x) the timing of all payments
hereunder is subject to Section 6.13 below and (y) the first such installment of any Severance Pay shall be in an amount covering the
time period from the date of termination of employment through the time of such first installment and (z) the release of all claims agreement
must be executed by Employee and become effective by its own terms within no more than 55 days after the date of termination. However,
notwithstanding the foregoing, to the extent any portion (or all) of a severance payment that would be paid in a lump sum would violate
Section 409A, then such amount shall instead be paid in installments pursuant to the installment payment provisions of this section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Confidentiality After Termination.</U> Immediately upon Employee's execution of this Agreement and on an on-going basis, the
Company agrees that it shall provide to Employee confidential information and trade secrets of the Company and its business (&quot;Confidential
Information&quot;). In consideration of, among other things, the Company's obligation to disclose confidential information to Employee
and his receipt of that confidential information, as well as the compensation and benefits set forth in this Agreement, Employee agrees
that during his employment with the Company and for the one year period following the termination of Employee's employment hereunder (the
&quot;Restricted Period&quot;), Employee will not, directly or indirectly, whether as an individual, employee, director, consultant, investor,
stockholder, partner, agent, principal, lender or advisor, or in any other capacity whatsoever, and whether personally or through other
persons:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>provide services, to the extent any such services require his use of Confidential Information, to any person, firm, corporation
or other business enterprise whose primary business involves (i) owning or operating diagnostic imaging centers or the provision of diagnostic
imaging services, (ii) providing administrative, management or other information services to radiology practices or (iii) providing management
services in the area of radiology, in each case unless he obtains the prior written consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>solicit, or attempt to encourage or solicit, any individual to leave the Company's employ for any reason or interfere in any other
manner with the employment relationships between the Company and its current or prospective employees or any employee who has been employed
by the Company within ninety days preceding Employee's termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>utilize Confidential Information to directly or indirectly induce or attempt to induce any provider, payor, customer, supplier,distributor,
licensee or other business relation of the Company to cease doing, or curtail, business with the Company or in any way interfere with
the existing business relationship between any such customer, supplier, distributor, licensee or other business relation and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any restriction
set forth in this paragraph is held to be unreasonable and/or unenforceable as written, Employee and the Company agree that the restriction
may be reformed to make it enforceable, and the restriction shall remain in full force and effect as reformed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Employee
acknowledges that the restrictions contained in this paragraph in view of the nature of the Company's business, are reasonable and necessary
to protect the Company's legitimate business interests and that any violation of this paragraph would result in irreparable injury to
the Company, and that monetary damages may not be sufficient to compensate the Company for any economic loss which may be incurred by
reason of breach of the foregoing restrictive covenants. In the event of a breach or a threatened breach by Employee of any provision
in this paragraph, the Company shall be entitled to cease making any and all payments otherwise payable to Employee on termination under
this Agreement and to seek a temporary restraining order and injunctive relief restraining Employee from the commission of any breach,
and to recover the Company's attorneys' fees, costs and expenses related to the breach or threatened breach. Nothing contained in this
paragraph shall be construed as prohibiting the Company from pursuing any other remedies available to it for any breach or threatened
breach, including, without limitation, the recovery of money damages, attorneys' fees, and costs. The restrictions in this paragraph shall
each be construed as independent of any other provisions in this Agreement, and the existence of any claim or cause of action by Employee
against the Company, whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Employee
violates any of the restrictions contained in this paragraph, the restrictive period will be suspended and will not run in favor of Employee
from the time of the commencement of any violation until the time when Employee cures the violation to the Company's satisfaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon Termination,
Employee shall return to the Company any and all Confidential Information relating to the Company and its Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: left"><U>General Provisions.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.6pt 0pt 6.85pt; text-align: justify; text-indent: 69.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Assignment.</U> Employee shall not assign or delegate any of his rights or obligations under this Agreement without the prior
written consent of the Company, and any attempted assignment without the Company's consent shall be void <I>ab initio.</I> The Company
may assign this Agreement to any successor of the Company or any purchaser of all or substantially all of the assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Entire Agreement.</U> This Agreement contains the entire agreement between the parties with respect to the subject matter hereof
and supersedes any and all prior agreements between the parties relating to such subject matter. In the case of any conflict between
the terms of this Agreement and any option agreement or similar instrument, the terms of this Agreement shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Modifications</U>. This Agreement may be changed or modified only by an agreement in writing signed by both parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Successors and Assigns.</U> The provisions of this Agreement shall inure to the benefit of, and be binding upon, the Company
and its successors and permitted assigns and Employee and Employee's legal representatives, heirs, legatees, distributees, assigns and
transferees by operation of law, whether or not any such person shall have become a party to this Agreement and have agreed in writing
to join and be bound by the terms and conditions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law.</U> This Agreement is performable in whole or in part in Los Angeles County, California wherein exclusive venue
shall lie for any proceeding, claim or controversy. This Agreement and the rights of the parties hereunder shall be governed by and construed
in accordance with the laws of the State of California, including all matters of construction, validity, performance and enforcement,
and without giving effect to principles of conflict of laws. Notwithstanding the foregoing, the Parties represent and agree that the Company
is engaged in interstate commerce, and as such Section 6.12 of this Agreement will be interpreted and enforced pursuant to the Federal
Arbitration Act, 9 U.S.C. Section 1, <I>et seq.,</I> and not any contrary state law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U>. If any provision of this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable,
the remaining provisions shall nevertheless continue in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Further Assurances.</U> The parties will execute such further instruments and take such further actions as may be reasonably
necessary to carry out the intent of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices.</U> Any notices or other communications required or permitted hereunder shall be in writing and shall be deemed received
by the recipient when delivered personally or, if mailed, five days after the date of deposit in the United States mail, certified or
registered, postage prepaid and addressed, in the case of the Company, to Radnet Management, Inc., 1510 Cotner Ave., Los Angeles, CA 90025-
3303, attention: Mark Stolper; and in the case of Employee, to the address shown for Employee on the signature page hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Waiver.</U> The failure of either party to enforce any provision of this Agreement shall not be construed as a waiver of
that provision, nor prevent that party thereafter from enforcing that provision of any other provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Legal Fees and Expenses.</U> In the event of any disputes under this Agreement, each party shall be responsible for its own
legal fees and expenses which it may incur in resolving such dispute, unless otherwise prohibited by applicable law or a court of competent
jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Counterparts</U>. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all of
which together shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Arbitration.</U> Any controversy, dispute or claim (&quot;Claim&quot;) whatsoever between Employee, on the one hand, and Company,
or any of its employees, directors, officers, and agents (collectively &quot;Company Parties&quot;), on the other hand, except as excluded
below, shall be resolved by binding arbitration, at the request of either party, in accordance with the Employment Dispute Resolution
Procedures of the American Arbitration Association or other similar organization agreed to by the parties. The claims covered by this
Agreement include, but are not limited to, claims for wages and other compensation, claims for breach of contract (express or implied),
tort claims, claims for discrimination or harassment (including, but not limited to, based on race, sex, sexual orientation, religion,
national origin, age, marital status, medical condition, or disability), and claims for violation of any federal, state, or other government
law, statute, regulation or ordinance, except for claims for worker's compensation or unemployment insurance benefits. Nothing contained
in this Agreement shall prohibit Employee from filing a charge of discrimination with the Equal Employment Opportunity Commission and/or
the Department of Fair Employment and Housing, and cooperating in the investigation of such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">This provision
does not apply to or cover claims based upon a benefit plan that contains an arbitration or other dispute resolution procedure, in which
case the provisions of such plan shall apply. Further, either Employee or the Company, in a court of competent jurisdiction, may seek
to compel arbitration under this Agreement, to enforce an arbitration award or to obtain preliminary injunctive and/or other equitable
relief in support of claims to be prosecuted in an arbitration to the extent allowed by California Code of Civil Procedure Section 1281.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">The chosen
arbitration administrator shall give each party a list of names drawn from its panel of employment arbitrators. The arbitrator shall apply
California substantive law and the California Evidence Code to the proceeding. The demand for arbitration must be in writing and made
within the applicable statute of limitations period. The arbitration shall take place in Los Angeles County, California. The parties shall
be entitled to conduct reasonable discovery, including, without limitation, conducting depositions, requesting documents and propounding
interrogatories. The arbitrator shall have the authority to resolve discovery disputes, including but not limited to determining what
constitutes reasonable discovery. The arbitrator shall prepare in writing and provide to the parties a decision and award, which shall
include factual findings and the reasons upon which a decision is based. Except as may be stated otherwise above, any and all arbitration
proceedings shall be conducted in accordance with the Employment Dispute Resolution Procedures of the AAA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 13.1pt 0pt 8.25pt; text-align: justify; text-indent: 105.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Except
as otherwise required by law, the decision of the arbitrator shall be binding and conclusive on the parties. Judgment upon the award rendered
by the arbitrator may be entered in any court having proper jurisdiction. The fees for the arbitrator shall be paid by Company. Each party
shall bear its or his own fees and costs incurred in connection with the arbitration except for any attorneys' fees or costs which are
awarded to a party by the Arbitrator pursuant to a statute or contract which provides for recovery of such fees and/or costs from the
other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">The arbitrator's
authority to resolve disputes and make awards under this Agreement is limited to disputes between (1) Employee as an individual and the
Company or any affiliates and (2) Employee as an individual and any past or present owner, shareholder, director, officer, partner, member,
associate, employee, intern, service provider, consultant or agent of the Company or any affiliates. No arbitration award or decision
will have any preclusive effect as to issues or arbitrable claims in any dispute with anyone who is not a named party to the arbitration.
Employee and the Company agree that each may file claims against the other only in their individual capacities, and may not file claims
as a plaintiff and/or participate as a class member in any pending or future class and/or collective action against the other. Employee
and the Company agree that any class, collective, or representative claims that are found not subject to arbitration under this Agreement
shall be resolved in court, and are stayed pending the outcome of the arbitration. Employee and the Company agree that a court, not an
arbitrator, shall determine whether any claims must proceed on a class or collective basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Except as
provided in this Agreement, arbitration shall be the sole, exclusive and final remedy for any dispute between Employee and the Company.
Both Company and the Employee understand and agree that by using arbitration to resolve any Claims between Employee and Company or any
or all the Company Parties they are giving up any right that they may have to a judge or jury trial with regard to those Claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Taxes and 409A.</U> All payments made by the Company to Employee will be subject to tax withholding in amounts determined by
the Company pursuant to applicable laws or regulations and Employee shall be solely responsible for any taxes, excise taxes, penalties
and/or interest imposed on Employee as a result of this Agreement or due to any other payments or benefits provided by the Company or
any Company affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">To the
maximum extent permitted, this Agreement is intended to not constitute a &quot;nonqualified deferred compensation plan&quot; within the
meaning of Internal Revenue Code Section 409A (&quot;Section 409A&quot;) but in any event will be interpreted to comply with Section 409A.
In the event this Agreement or any benefit paid under this Agreement or otherwise by the Company or any Company affiliate to Employee
is deemed to be subject to Section 409A, Employee consents to the Company's adoption of such conforming amendments as the Company deems
advisable or necessary, in its sole discretion (but without an obligation to do so), to comply with Section 409A and avoid the imposition
of taxes under Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">For purposes
of this Agreement, a termination of employment means a &quot;separation from service&quot; as defined in Section 409A. Each payment made
pursuant to any provision of this Agreement shall be considered a separate payment and not one of a series of payments for purposes of
Section 409A. To the extent any nonqualified deferred compensation payment to Employee could be paid in one or more of Employee's taxable
years depending upon Employee completing certain employment related actions, then any such payments will commence or occur in the later
taxable year to the extent required by Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">If upon Employee's
&quot;separation from service&quot; within the meaning of Section 409A, Employee is then a &quot;specified employee&quot; (as defined
in Section 409A) of RNI, then solely to the extent necessary to comply with Section 409A and avoid the imposition of taxes under Section
409A, the Company (or RNI) shall defer payment of &quot;nonqualified deferred compensation&quot; subject to Section 409A payable as a
result of and within six (6) months following such &quot;separation from service&quot; until the earlier of (i) the first business day
of the seventh month following Employee's &quot;separation from service,&quot; or (ii) ten (10) days after the Company receives written
confirmation of Employee's death. Any such delayed payments shall be made without interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company and
Employee have executed this Agreement, effective as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 49%"><B>COMPANY:</B></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
  <TD STYLE="width: 49%"><B>EMPLOYEE:</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>RADNET MANAGEMENT, INC.</B></TD>
    <TD>&nbsp;</TD>
  <TD><B>Gregory Sorensen, M.D.</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid">/s/ Howard G. Berger</TD>
    <TD>&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid">/s/ Gregory Sorensen, M.D.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-left: 10pt">Howard G. Berger, M.D., President</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.05pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.05pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.05pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.05pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.05pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.05pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.05pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.05pt"><B></B></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.05pt"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>radnet_ex9901.htm
<DESCRIPTION>EARNINGS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><IMG SRC="image_001.jpg" ALT="" STYLE="height: 74.25pt; width: 172.5pt"></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR IMMEDIATE RELEASE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 12pt"><B>RadNet Reports Second Quarter Financial
Results, with Record Quarterly Revenue and Adjusted EBITDA<SUP>(1)</SUP>, and Updates 2023 Financial Guidance Ranges </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Revenue increased 13.9% to a quarterly record of $403.7 million in the
second quarter of 2023 from $354.4 million in the second quarter of 2022; Excluding Revenue from our Artificial Intelligence (&ldquo;AI&rdquo;)
reporting segment, Revenue from the Imaging Centers reporting segment in the second quarter of 2023 was $401.3 million, an increase of
13.8% from last year&rsquo;s second quarter of $352.8 million</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Excluding losses from our AI reporting segment, Adjusted EBITDA<SUP>(1)</SUP>
from the Imaging Centers reporting segment was a quarterly record of $63.7 million in the second quarter of 2023 as compared with $55.5
million in the second quarter of 2022, an increase of 14.7%; Adjusted EBITDA<SUP>(1)</SUP>, including losses from our AI reporting segment,
was $60.4 million in the second quarter of 2023 as compared with $51.3 million in the second quarter of 2022, an increase of 17.7%</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>After adjusting for certain unusual or one-time items impacting the quarter
and AI losses, Adjusted Earnings<SUP>(3)</SUP> was $14.9 million and diluted Adjusted Earnings Per Share<SUP>(3)</SUP> was $0.24 for the
second quarter of 2023 compared with Adjusted Earnings<SUP>(3)</SUP> of $8.6 million and diluted Adjusted Earnings Per Share<SUP>(3)</SUP>
of $0.15 for the second quarter of 2022 </I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Aggregate procedural volumes increased 11.4% and same-center procedural
volumes increased 7.1% compared with the second quarter of 2022</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>On June 16<SUP>th</SUP>, RadNet completed its upsized public offering
of common stock, raising $246 million of net proceeds; At June 30, 2023, RadNet had a $357 million cash balance</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>RadNet increases full-year 2023 guidance levels for Revenue and Adjusted
EBITDA<SUP>(1)</SUP> from the Imaging Center Segment</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0 0pt 0.25in; font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LOS ANGELES, California, August 9, 2022 &ndash;
RadNet, Inc. (NASDAQ: RDNT),</B> a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging
services through a network of 363 owned and operated outpatient imaging centers, today reported financial results for its second quarter
of 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief Executive
Officer of RadNet, commented, &ldquo;I am very pleased with the continued strength of our core imaging center business. In our Imaging
Center segment, Revenue increased 13.8% and Adjusted EBITDA<SUP>(1)</SUP> increased 14.7% from last year&rsquo;s second quarter. Our record
quarterly Revenue and Adjusted EBITDA<SUP>(1)</SUP> were driven by 11.4% aggregate and 7.1% same-center procedural volume growth relative
to last year&rsquo;s second quarter, along with effective expense management. We continue to benefit from the steady growth in the overall
industry as well as the accelerating shift from hospital-based procedures to lower-cost, more convenient freestanding centers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;As a result of the positive trends we are
experiencing in our core business and the strong financial performance of the first and second quarters, we have elected to revise upwards
our 2023 full year Imaging Center segment Revenue and Adjusted EBITDA<SUP>(1)</SUP> guidance levels in anticipation of financial results
that we believe will exceed both our original guidance ranges and those that were revised after our first quarter results,&rdquo; added
Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger continued, &ldquo;Our AI segment has
begun to demonstrate accelerated growth. Compared with last year&rsquo;s second quarter, our AI revenue grew 52.8%. Additionally, for
the first six months of 2023 compared with last year&rsquo;s same six-month period, our AI division Revenue grew 109%. We are experiencing
increasing enrollment as we roll-out our Enhanced Breast Cancer Detection program and we are encouraged about its future success. While
this service offering continues to gain acceptance from our patients and referring physicians, we have spent a considerable amount time
and effort in optimizing the educational benefits and pricing to achieve wider adoption and exposure. These efforts purposefully slowed
the roll-out by 90-120 days, impacting the implementation and delaying the financial performance of the program.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;To assist with the growth and commercialization
of our digital health businesses, which in addition to our AI initiatives, includes our eRAD radiology informatics businesses, we are
pleased to welcome the addition to our management team of Sham Sokka and Sanjog Misra, both with extensive experience in medical software
and AI businesses. These senior management additions emphasize our commitment to, and confidence in our digital businesses. We believe
these digital health initiatives will have a transformative impact on both RadNet&rsquo;s AI and Imaging Center businesses, and positions
us to be a significant agent of change in our dynamic industry, an industry that is driven by technology and innovation,&rdquo; said Dr.
Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;In response to the heavy volume demands
we are experiencing in many of our imaging center regions, we are growing capacity and access through the de novo strategy we embarked
on last year. We opened one de novo facility during the second quarter, and anticipate opening five additional centers by year end as
well as another six facilities planned in 2024. Our hospital and health system joint venture offerings continue to grow with new system
partnerships and through expansion of existing relationships,&rdquo; concluded Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Second Quarter Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the second quarter of 2023, RadNet reported
Revenue from its Imaging Centers reporting segment of $401.3 million and Adjusted EBITDA<SUP>(1)</SUP> of $63.7 million, which exclude
Revenue and Losses from the AI reporting segment. As compared with last year&rsquo;s second quarter, Revenue increased $48.5 million (or
13.8%) and Adjusted EBITDA<SUP>(1)</SUP> increased $8.2 million (or 14.7%). Including our AI reporting segment, Revenue was $403.7 million
in the second quarter of 2023, an increase of 13.9% from $354.4 million in last year&rsquo;s second quarter. Including the losses of the
AI reporting segment, Adjusted EBITDA<SUP>(1)</SUP> was $60.4 million in the second quarter of 2023 and $51.3 million in the second quarter
of 2022, an increase of 17.7%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the second quarter of 2023, RadNet reported
Net Income of $8.4 million as compared with $7.9 million for the second quarter of 2022. Diluted Net Income Per Share for the second quarter
of 2023 was $0.12, compared with a Diluted Net Income Per Share of $0.13 in the second quarter of 2022, based upon a weighted average
number of diluted shares outstanding of 60.9 million shares in 2023 and 57.0 million shares in 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were a number of unusual or one-time items
impacting the second quarter including: $4.2 million of non-cash gain from interest rate swaps; $1.0 million expense related to the change
in valuation of contingent consideration related to completed acquisitions; $759,000 expense related to leases for our de novo facilities
under construction that have yet to open their operations; and $8.7 million of pre-tax losses related to our AI reporting segment. Adjusting
for the above items, Adjusted Earnings<SUP>(3)</SUP> from the Imaging Centers reporting segment was $14.9 million and diluted Adjusted
Earnings Per Share<SUP>(3)</SUP> was $0.24 during the second quarter of 2023. This compares with Adjusted Earnings<SUP>(3)</SUP> of $8.6
million and diluted Adjusted Earnings Per Share<SUP>(3)</SUP> of $0.15 during the second quarter of 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also, affecting Net Income in the second quarter
of 2023 were certain non-cash expenses and unusual items including: $4.9 million of non-cash employee stock compensation expense resulting
from the vesting of certain options and restricted stock; $1.9 million of severance paid in connection with headcount reductions related
to cost savings initiatives; $77,000 loss on the disposal of certain capital equipment; and $748,000 of non-cash amortization of deferred
financing costs and loan discounts related to financing fees paid as part of our existing credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the second quarter of 2023, as compared with
the prior year&rsquo;s second quarter, MRI volume increased 11.8%, CT volume increased 11.3% and PET/CT volume increased 18.3%. Overall
volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 11.4% over the
prior year&rsquo;s second quarter. On a same-center basis, including only those centers which were part of RadNet for both the second
quarters of 2023 and 2022, MRI volume increased 7.3%, CT volume increased 6.3% and PET/CT volume increased 18.8%. Overall same-center
volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 7.1% over the
prior year&rsquo;s same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Six Month Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the six month period of 2023, RadNet reported
Revenue from its Imaging Centers reporting segment of $789.8 million and Adjusted EBITDA<SUP>(1)</SUP> Excluding Losses from the AI reporting
segment of $116.4 million. Revenue increased $95.8 million (or 13.8%) and Adjusted EBITDA<SUP>(1)</SUP> increased $19.1 million (or 19.7%).
Including our AI reporting segment Revenue of $4.5 million, Revenue was $794.3 million in the six months of 2023, an increase of 14.1%
from $696.1 million in last year&rsquo;s six-month period. Including the AI reporting segment Adjusted EBITDA<SUP>(1)</SUP> losses, Adjusted
EBITDA<SUP>(1) </SUP>for the six month period of 2023 was $108.6 million as compared with $89.5 million in the same six month period of
2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the six-month period in 2023, RadNet reported
Net Loss of $12.6 million, compared with Net Income of $10.9 million in the first six months of 2022. Per share Net Loss for the first
six months of 2023 was $(0.21), compared to a diluted Net Income per share of $0.18 in the same six-month period of 2022 (based upon a
weighted average number of diluted shares outstanding of 59.2 million in 2023 and 56.7 million in 2022).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Affecting Net Income for the six month period
of 2023 were certain non-cash expenses and non-recurring items including: $17.1 million of non-cash employee stock compensation expense;
$16.2 million of pre-tax losses related to our AI reporting segment; $2.0 million of severance paid in connection with headcount reductions
related to cost savings initiatives; $1.7 million of non-operational rent expense associated with certain un-opened de novo locations:
$656,000 loss on the disposal of certain capital equipment; $66,000 of non-cash gain from interest rate swaps; and $1.5 million of amortization
of deferred financing costs and loan discount related to our existing credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>2023 Guidance Update</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet amends its previously announced guidance
levels as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Imaging Center Segment</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 25%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 25%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Original Guidance Range</U></FONT></TD>
    <TD STYLE="text-align: center; width: 25%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revised Guidance Range After Q1 Results</U></FONT></TD>
    <TD STYLE="text-align: center; width: 25%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revised Guidance Range After Q2 Results</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Net Revenue</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,525 - $1,575 million</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,550 - $1,600 million</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,575 - $1,610 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted EBITDA<SUP>(1)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$220 - $230 million</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$225 - $235 million</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$232 - $242 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital Expenditures<SUP>(a)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$105 - $115 million</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$110 - $120 million</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unchanged</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash Interest Expense<SUP>(c)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$35 - $40 million</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$45 - $50 million</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unchanged</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Free Cash Flow <SUP>(b)(2)</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$70 - $80 million</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$65 - $70 million</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unchanged</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Artificial Intelligence Segment</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 25%; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD>
    <TD STYLE="vertical-align: bottom; width: 25%; text-align: center"><FONT STYLE="font-size: 10pt"><U>Original Guidance Range</U></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 25%; text-align: center"><FONT STYLE="font-size: 10pt"><U>Revised Guidance Range After Q1 Results</U></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 25%; text-align: center"><FONT STYLE="font-size: 10pt"><U>Revised Guidance Range After Q2 Results</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Total Net Revenue</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">$16 - $18 million</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">$16 - $18 million</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">$11 - $13 million</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Adjusted EBITDA<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">$(9) - $(11) million</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">$(9) - $(11) million</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">$(11) - $(13) million</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 9pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9pt">Net
                                            of proceeds from the sale of equipment, imaging centers and joint venture interests, and
                                            excludes New Jersey Imaging Network capital expenditures.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 9pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9pt">Defined
                                            by the Company as Adjusted EBITDA<SUP>(1)</SUP> less Capital Expenditures and Cash Paid for
                                            Interest.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 9pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9pt">Excludes
                                            payments to counterparties on interest rate swaps and nets interest income from our cash
                                            balance recorded in Other Income.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;We have increased
our guidance ranges in our core Imaging Center reporting segment for Revenue and Adjusted EBITDA</FONT><SUP>(1)</SUP> <FONT STYLE="font-size: 10pt">to
reflect the strong financial results in the first half of 2023 as compared with our budget. Additionally, we have lowered our guidance
ranges for Revenue and Adjusted EBITDA</FONT><SUP>(1)</SUP> <FONT STYLE="font-size: 10pt">for the AI Segment to reflect delays resulting
from optimizing the implementation of our Enhanced Breast Cancer Detection program.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Conference Call for Today</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief Executive
Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss its second quarter
2023 results on Tuesday, August 8th, 2023 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Conference Call Details:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: Tuesday, August 8, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time: 10:30 a.m. Eastern Time</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dial In-Number: 844-826-3035</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">International Dial-In Number: 412-317-5195</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">It is recommended
that participants dial in approximately 5 to 10 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and
archived webcasts available at </FONT>https://viavid.webcasts.com/starthere.jsp?ei=1626353&amp;tp_key=fb76d167b0 <FONT STYLE="font-size: 10pt">or
http://www.radnet.com under the &ldquo;Investors&rdquo; menu section and &ldquo;News Releases&rdquo; sub-menu of the website. An archived
replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international
callers, and using the passcode 10181301.</FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>About RadNet, Inc.</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet, Inc., is the leading national provider
of freestanding, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence)
in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 363 owned and/or operated outpatient
imaging centers. RadNet's markets include Arizona, California, Delaware, Florida, Maryland, New Jersey and New York. Together with affiliated
radiologists, inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 9,000 employees. For
more information, visit http://www.radnet.com.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>Forward Looking Statements</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains &ldquo;forward-looking
statements&rdquo; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking
statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and
strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified
by words such as: &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;goal,&rdquo; &ldquo;seek,&rdquo; &ldquo;believe,&rdquo;
&ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;strategy,&rdquo; &ldquo;future,&rdquo; &ldquo;likely,&rdquo;
&ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will&rdquo; and similar references to future periods. Forward-looking statements in this
press release include, among others, statements we make regarding response to and the expected future impacts of COVID-19, including statements
about our anticipated business results, balance sheet and liquidity and our future liquidity, burn rate and our continuing ability to
service or refinance our current indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">Forward-looking statements are neither historical
facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties,
risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and
financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue
reliance on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to
differ materially from those indicated in the forward-looking statements include, among others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital to fund
our business;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to service our indebtedness, make
principal and interest payments as those payments become due and remain in compliance with applicable debt covenants, in addition to our
ability to refinance such indebtedness on acceptable terms;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in general economic conditions nationally
and regionally in the markets in which we operate;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital to fund
the expansion of our business and improvements to our existing facilities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to maintain our current credit rating
and the impact on our funding costs and competitive position if we do not do so;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our ability to acquire, develop, implement and monetize technology, digital health initiatives, artificial
intelligence algorithms and applications;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">volatility in interest and exchange rates, or
credit markets;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the adequacy of our cash flow and earnings to
fund our current and future operations;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in service mix, revenue mix and procedure
volumes; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">delays in receiving payments for services provided;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">increased bankruptcies among our partner physicians
or joint venture partners;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the impact of the political environment and related
developments on the current healthcare marketplace and on our business, including with respect to the future of the Affordable Care Act;
</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the extent to which the ongoing implementation
of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof by federal and state regulators or
related litigation result in a reduction in coverage or reimbursement rates for our services, or other material impacts to our business;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">closures or slowdowns and changes in labor costs
and labor difficulties, including stoppages affecting either our operations or our suppliers' abilities to deliver supplies needed in
our facilities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the occurrence of hostilities, political instability
or catastrophic events; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the emergence or reemergence of and effects related
to future pandemics, epidemics and infectious diseases; and </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">noncompliance by us with any privacy or security
laws or any cybersecurity incident or other security breach by us or a third party involving the misappropriation, loss or other unauthorized
use or disclosure of confidential information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement contained in this
current report is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation
to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of
changed circumstances, new information, future developments or otherwise, except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Regulation G: GAAP and Non-GAAP Financial
Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This release contains certain financial information
not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results. The Company believes
that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance. The Company believes
this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in
the affected period and provides a basis for measuring the Company's financial condition against other quarters. Such information should
not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled
measures of other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial
information prepared in accordance with GAAP. Reconciliation of this information to the most comparable GAAP measures is included in this
release in the tables which follow.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CONTACTS: </I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>RadNet, Inc.</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mark Stolper, 310-445-2800</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Executive Vice President and Chief Financial
Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 406.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, 2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 50pt; font-size: 10pt; font-weight: bold; text-align: left">ASSETS</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">CURRENT ASSETS</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left">Cash and Cash equivalents</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">356,651</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">127,834</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Accounts receivable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">174,481</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">166,357</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Due from affiliates</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">22,240</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,971</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">49,319</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">54,022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total current assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">602,691</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">367,184</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Property and equipment, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">576,094</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">565,961</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Operating lease right-of-use assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">627,130</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">603,524</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total property, plant, equipment and right-of-use assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,203,224</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,169,485</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">OTHER ASSETS</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Goodwill</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">687,879</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">677,665</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Other intangible assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100,433</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">106,228</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Deferred financing costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,962</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,280</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Investment in joint ventures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">52,492</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">57,893</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Deposits and other</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">56,609</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">53,172</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">2,705,290</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">2,433,907</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 50pt; font-size: 10pt; font-weight: bold; text-align: left">LIABILITIES AND EQUITY</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">CURRENT LIABILITIES</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Accounts payable, accrued expenses and other</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">333,224</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">369,595</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Due to affiliates</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,463</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,100</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Deferred revenue</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,054</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,021</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Current operating lease liability</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">59,504</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">57,607</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Current portion of notes payable</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">15,989</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">12,400</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Total current liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">434,234</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">466,723</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">LONG-TERM LIABILITIES</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Long-term operating lease liability</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">628,845</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">604,117</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Notes payable, net of current portion</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">848,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">839,344</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Deferred tax liability, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,005</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,256</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Other non-current liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">22,869</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">23,015</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,944,286</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,942,455</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">EQUITY</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">RadNet, Inc. stockholders' equity:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -5pt; padding-left: 15pt; font-size: 10pt; text-align: left">Common stock - $.0001 par value, 200,000,000 shares authorized; 67,669,564 and 57,723,125 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Additional paid-in-capital</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">703,593</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">436,288</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Accumulated other comprehensive loss</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(15,183</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(20,677</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(95,258</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(82,622</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total RadNet, Inc.'s stockholders equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">593,159</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">332,995</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Noncontrolling interests</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">167,845</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">158,457</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Total equity</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">761,004</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">491,452</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and equity</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,705,290</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,433,907</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><BR STYLE="clear: both">
</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended June 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Six Months Ended June 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">REVENUE</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 40%; font-size: 10pt; text-align: left">Service fee revenue</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">363,918</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">316,501</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">716,338</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">619,776</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Revenue under capitation arrangements</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">39,797</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">37,874</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">77,941</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">76,365</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Total service revenue</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">403,715</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">354,375</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">794,279</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">696,141</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Cost of operations, excluding depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">345,147</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">305,775</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">697,012</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">620,813</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">32,180</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">28,862</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,495</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">55,980</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Loss (gain) on sale and disposal of equipment and other</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">77</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">81</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">656</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,209</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Severance costs</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,870</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">99</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,004</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">300</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">379,274</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">334,817</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">763,167</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">678,302</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">INCOME (LOSS) FROM OPERATIONS</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">24,441</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">19,558</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">31,112</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">17,839</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Interest expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,039</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">11,385</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">31,761</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">22,978</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Equity in earnings of joint ventures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,423</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,748</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,851</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(5,266</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(4,159</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(6,306</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(66</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(27,125</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other expenses (income)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">40</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(7</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,472</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">158</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Total other expense (income)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">10,497</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,324</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">30,316</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(9,255</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">INCOME (LOSS) BEFORE INCOME TAXES</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">13,944</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">17,234</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">796</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">27,094</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Benefit from (provision for) income taxes</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">614</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(3,403</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(521</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(4,900</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">NET INCOME (LOSS)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">14,558</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">13,831</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">275</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">22,194</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Net income (loss) attributable to noncontrolling interests</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6,189</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,926</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">12,911</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">11,276</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">8,369</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">7,905</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(12,636</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">10,918</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">0.14</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">0.14</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(0.21</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">0.20</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">0.12</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">0.13</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(0.21</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">0.18</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Basic</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">59,880,803</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">56,059,824</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">59,221,453</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">55,683,335</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">60,916,985</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">56,966,548</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">59,221,453</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">56,666,290</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENTS OF CASHFLOWS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Six Months Ended June 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left">Net income</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">275</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">22,194</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Adjustments to reconcile net income to net cash provided by operating activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,495</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">55,980</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Amortization of operating lease assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">31,601</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">34,055</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Equity in earnings of joint ventures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,851</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(5,266</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Distributions from joint ventures</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,947</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Amortization deferred financing costs and loan discount</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,494</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,295</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Loss (Gain) non sale and disposal of equipment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">656</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,209</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Amortization of cash flow hedge</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,844</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,847</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(66</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(27,125</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Stock-based compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17,055</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15,795</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of contingent consideration</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,098</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,287</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Accounts receivable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(8,124</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(30,566</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Other current assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,703</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(709</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Other assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(6,590</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,282</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Deferred taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,249</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,732</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Operating lease liability</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(28,582</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(32,219</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Deferred revenue</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,033</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,565</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Accounts payable, accrued expenses and other</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">14,952</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">32,092</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash provided by operating activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">100,691</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">65,744</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Purchase of imaging facilities and other acquisitions</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(10,315</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(26,009</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Purchase of property and equipment and other</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(95,380</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(72,659</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Proceeds from sale of equipment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">73</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,121</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Equity contributions in existing and purchase of interest in joint ventures</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(288</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,441</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(105,910</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(95,988</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Principal payments on notes and leases payable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,051</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Payments on Term Loan Debt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,376</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(6,625</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Distributions paid to noncontrolling interests</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(3,523</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Proceeds from issuance of common stock</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">246,201</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Proceeds from issuance of common stock upon exercise of options</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">51</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash used in financing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">234,302</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(6,625</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">EFFECT OF EXCHANGE RATE CHANGES ON CASH</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(266</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,433</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">228,817</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(35,436</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">CASH AND CASH EQUIVALENTS, beginning of period</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">127,834</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">134,606</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, end of period</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">356,651</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">99,170</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Cash paid during the period for interest</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">39,301</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">19,687</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Cash paid during the period for income taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">201</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">126</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Cash received (paid) during the period from cash flow hedge</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">6,715</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(4,248</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Cash Interest Received on our Cash Balance</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">2,681</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RECONCILIATION OF GAAP NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS TO ADJUSTED EBITDA</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended June 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Six Months Ended June 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; width: 40%; font-size: 10pt; text-align: left; text-indent: -5pt">Net income (loss) attributable to Radnet, Inc. common stockholders</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">8,369</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">7,905</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">(12,636</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">10,918</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Income taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(614</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,403</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">521</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,900</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Interest expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,039</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">11,385</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">31,761</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">22,978</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Severance costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,870</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">99</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,004</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">300</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">32,180</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">28,862</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,495</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">55,980</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Non-cash employee stock-based compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,870</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,693</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17,056</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15,795</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Loss (gain) on sale and disposal of equipment and other</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">77</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">81</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">656</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,209</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(4,159</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(6,306</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(66</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(27,125</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Other expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">40</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,472</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">158</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Legal settlements</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,197</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Contingent Consideration</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,014</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,630</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Non-operational rent expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">759</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,222</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,718</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,160</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Adjusted EBITDA Including Losses from AI Segment</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">60,445</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">51,337</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">108,611</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">89,470</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Losses from AI Segment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,285</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,207</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,779</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,792</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Adjusted EBITDA excluding Losses from AI Segment</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">63,730</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">55,544</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">116,390</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">97,262</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">PAYOR CLASS BREAKDOWN</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">Second Quarter</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 53%; font-size: 10pt; text-align: left">Commercial Insurance</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">58.3%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Medicare</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">22.2%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Capitation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9.9%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Medicaid</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.5%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Workers Compensation/Personal Injury</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3.2%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">Other</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4.1%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Total</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET PAYMENTS BY MODALITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">Second Quarter</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">Full Year</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">Full Year</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">Full Year</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%; font-size: 10pt">MRI</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">36.7%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">36.8%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">36.0%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">35.4%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">CT</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16.9%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17.5%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17.2%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17.6%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">PET/CT</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.4%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.8%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.5%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">X-ray</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.6%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.7%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3.9%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7.3%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Ultrasound</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12.6%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12.7%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12.3%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Mammography</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15.6%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15.3%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16.1%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15.7%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Nuclear Medicine</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.8%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.9%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">Other</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4.0%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4.5%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4.6%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4.7%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100.0%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>PROCEDURES BY MODALITY*</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">Second Quarter</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">Second Quarter</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 46%; font-size: 10pt">MRI</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">387,619</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">346,598</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">CT</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">235,138</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">211,221</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">PET/CT</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15,036</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12,710</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Nuclear Medicine</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,463</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,857</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Ultrasound</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">620,660</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">552,941</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Mammography</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">450,747</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">393,515</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">X-ray and Other</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">832,719</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">763,334</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,551,382</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,290,176</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; * Volumes include wholly owned and joint venture centers.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">SCHEDULE OF ADJUSTED EARNINGS AND EARNINGS PER SHARE <FONT STYLE="font: normal 700 10pt Times New Roman, Times, Serif"><SUP>(3)</SUP></FONT></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">NET INCOME ATTRIBUTABLE TO RADNET, INC.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 66%; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">COMMON STOCKHOLDERS</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,369</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">7,905</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Subtract non-cash change in fair value of interest rate swaps (i)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(4,159</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(6,306</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Non-operational rent expenses (iii)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">759</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,222</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Contingent Consideration</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,014</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">AI Segment Losses (iv)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">8,655</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,892</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Total adjustments - loss (gain)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,269</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">808</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Subtract tax impact of Adjustments (ii)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">276</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(160</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left">Tax effected impact of adjustments</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,545</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">648</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">TOTAL ADJUSTMENT TO NET INCOME ATTRIBUTABLE</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">TO RADNET, INC. COMMON SHAREHOLDERS</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6,545</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">648</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">ADJUSTED NET INCOME ATTRIBUTABLE TO RADNET, INC.</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">14,914</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,553</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left">COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt">Diluted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,916,985</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">56,966,548</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">ADJUSTED DILUTED NET INCOME PER SHARE</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.24</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.15</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 2pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 20pt; text-align: left">(i)</TD><TD STYLE="text-align: justify">Impact from the change in fair value of the swpas during the quarter.
Excludes the amortization of the accumulation of the changes in fair value out of Other Comprehensive Income that existed prior to the
hedges becoming ineffective.</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 20pt; text-align: left">(ii)</TD><TD STYLE="text-align: justify">Tax effected using (4.40)% and 19.75% blended federal and state
effective tax rate for the second quarter of 2023 and 2022, respectively.</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 20pt; text-align: left">(iii)</TD><TD STYLE="text-align: justify">Represents rent expense associated with de novo sites under construction
prior to them becoming operational.</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 20pt; text-align: left">(iv)</TD><TD STYLE="text-align: justify">Represents losses before income taxes from Artificial Intelligence
reporting segment.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
<U><BR STYLE="clear: both">
</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Footnotes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>&nbsp;</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(1)</SUP> The Company defines Adjusted EBITDA
as earnings before interest, taxes, depreciation and amortization, each from continuing operations and adjusted for losses or gains on
the sale of equipment, other income or loss, debt extinguishments and non-cash equity compensation. Adjusted EBITDA includes equity earnings
in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash
or extraordinary and one-time events taken place during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA is reconciled to its nearest comparable
GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management and the healthcare
industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not
be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data
presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a
measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented,
may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(2)</SUP> As noted above, the Company defines
Free Cash Flow as Adjusted EBITDA less total Capital Expenditures (whether completed with cash or financed) and Cash Interest paid. Free
Cash Flow is a non-GAAP financial measure. The Company uses Free Cash Flow because the Company believes it provides useful information
for investors and management because it measures our capacity to generate cash from our operating activities. Free Cash Flow does not
represent total cash flow since it does not include the cash flows generated by or used in financing activities. In addition, our definition
of Free Cash Flow may differ from definitions used by other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Free Cash Flow should not be considered a measure
of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives
to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the
consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined
in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable
to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(3)</SUP> The Company defines Adjusted Earnings
(Loss) Per Share as net income or loss attributable to RadNet, Inc. common stockholders and excludes losses or gains on the disposal of
equipment, loss on debt extinguishments, bargain purchase gains, severance costs, loss on impairment, loss or gain on swap valuation,
gain on extinguishment of debt, unusual or non-recurring entries that impact the Company&rsquo;s tax provision and any other non-recurring
or unusual transactions recorded during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted Earnings (Loss) Per Share is reconciled
to its nearest comparable GAAP financial measure. Adjusted Earnings (Loss) Per Share is a non-GAAP financial measure used as analytical
indicator by RadNet management and the healthcare industry to assess business performance. Adjusted Earnings Per Share should not be considered
a measure of financial performance under GAAP, and the items excluded from Adjusted Earnings Per Share should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data
presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted Earnings Per Share
is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as
presented, may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>radnet_ex9902.htm
<DESCRIPTION>TRANSCRIPT OF CONFERENCE CALL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #00339A"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 458px; width: 640px"><BR STYLE="clear: both">
&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #00339A"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>C O R P O R A T E P A R T I
C I P A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger, </B><I>President, Chief Executive
Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper, </B><I>Chief Financial Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>C O N F E R E N C E C A L L
P A R T I C I P A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut, </B><I>Jefferies</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nathan Malewicki, </B><I>Raymond James</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Yuan Zhi, </B><I>B. Riley Securities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal, </B><I>Sidoti</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>P R E S E N T A T I O N</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good day, and welcome to the RadNet Second Quarter
2023 Financial Results Call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Operator Instructions) Please note today&rsquo;s
event is being recorded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I would now like to turn the conference over to
Mark Stolper, Chief Financial Officer. Please go ahead, sir.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Good morning ladies and gentlemen,
and thank you for joining Dr. Howard Berger and me today to discuss RadNet&rsquo;s second quarter 2023 results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we begin today, we'd like to remind everyone
of the Safe Harbor statement under the Private Securities Litigation Reform Act of 1995. This presentation contains forward-looking statements
within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning anticipated future
financial and operating performance, RadNet&rsquo;s ability to continue to grow the business by generating patient referrals and contracts
with radiology practices, recruiting and retaining technologists, receiving third party reimbursement for diagnostic imaging services,
successfully integrating acquired operations, generating revenue and Adjusted EBITDA for the acquired operations as estimated, among others,
are forward-looking statements within the meaning of the Safe Harbor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are based on Management's
current preliminary expectations and are subject to risks and uncertainties which may cause RadNet&rsquo;s actual results to differ materially
from the statements contained herein. These risks and uncertainties include those risks set forth in RadNet&rsquo;s reports filed with
the SEC from time to time, including RadNet's annual report on Form 10-K for the year ended December 31, 2022. Undue reliance should not
be placed on forward-looking statements, especially guidance on future financial performance which speaks only as of the date it is made.
RadNet undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances
after the date they were made, or to reflect the occurrence of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that, I'd like to turn the call over to Dr.
Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you Mark. Good morning everyone, and thank
you for joining us today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On today's call, Mark and I plan to provide you
with highlights from our second quarter 2023 results, give you more insight into factors which affected this performance and discuss our
future strategy. After our prepared remarks, we will open the call to your questions. I'd like to thank all of you for your interest in
our Company and for dedicating a portion of your day to participate in our conference call this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I am very pleased with our performance in the
second quarter. It was the strongest quarter in our Company&rsquo;s history with record revenue and Adjusted EBITDA. Relative to last
year&rsquo;s second quarter, our core imaging center segment revenue increased 13.8% and imaging center Adjusted EBITDA increased 14.7%.
This performance was driven in part by heavy demand in virtually all of our markets. Aggregate procedural volumes increased 11.4% and
same center procedural volumes increased 7.1% compared with the second quarter of 2022. This heavy demand is being driven by a number
of factors that we have highlighted in recent quarters which we believe will continue to create strong growth for years to come.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">First within the healthcare delivery system, there
is a growing focus on preventative non-invasive medicine with keen interest in the earlier and more accurate detection of diseases. As
managed care grows, risk-based provider models become more common and population health screening becomes more prevalent, diagnostic imaging
will grow in its importance. Second, as the population expands and ages, diagnostic imaging is used with greater frequency. In fact, Medicare
lives utilize imaging two to three times more often than younger commercial lives. Third, technology in our industry continues to evolve
and improve, creating additional medical indications for ordering diagnostic imaging tests. Advances in MRI technology and post-processing
software have shortened scanning times, increased throughput and capacity, and improved imaging quality. New contrast materials and radioactive
(inaudible) are driving novel applications such as PSMA, or prostate specific membrane antigen, PET scans and Alzheimer&rsquo;s imaging.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While these factors explain the steady growth
in our industry, there is also a market shift taking place within diagnostic imaging that is also working in RadNet&rsquo;s favor. Increasingly,
patient volumes are being directed away from expensive hospital-based imaging facilities towards more cost effective ambulatory outpatient
settings. Freestanding outpatient centers offer more convenient and lower cost services that are preferred by patients, referring physicians
and payors. We believe these favorable trends will continue to help drive our future same center performance and present growth opportunities
for years to come.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To address these trends, we&rsquo;ve opened one
new facility and we currently have 12 de novo facilities in various stages of development which will open for operation in the second
half of 2023 and throughout 2024. These facilities are located in markets where we have patient backlogs, require additional capacity,
or where we currently lack access points to service patient populations in need. While these projects require us to make capital investments
above our normal spending, we are confident these centers will be material contributors to our long-term performance and growth. While
the labor market remains challenging, we have been more successful in filling open positions and have been reducing our reliance on expensive
temporary staffing services and overtime hours of our existing team members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We continue our efforts to grow our hospital and
health system partnership initiatives. Currently 120 of our 353 centers, or 33% are held within health system partnerships. Our partnerships
are some of the largest and most successful systems in our geographies, including RWJBarnabas, Memorial Care, Dignity Health, Lifebridge,
University of Maryland Medical System, the Adventist Health System, Cedars Sinai, and others. These and other health systems are seeking
solutions for long term strategies around outpatient imaging and have recognized that cost effective and efficient freestanding imaging
centers will continue to capture market share from hospitals as payors and patients migrate their site of care towards lower cost high
quality solutions. We expect by year end, our JV centers could represent closer to 40% of our total center accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our hospital and health system partners have been
instrumental in increasing our procedural volumes through their relationships with physician partners. Additionally, our JV partners are
helpful in providing support, if needed, in establishing long term, equitable outpatient reimbursement rates for our services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the strong performance in the first
half of this year and the confidence we are feeling for the remainder of the 2023 period, we have elected to increase key financial guidance
levels in our core imaging center operating segment for 2023. Mark in his prepared remarks will review the increases we made to our revenue
and Adjusted EBITDA guidance levels upon releasing our financial results this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lastly, we continue to make progress with our
AI and digital health initiatives. You may have seen a recent press release announcing two additions to our executive team who will be
focused on driving growth in our digital health businesses to include both clinical and generative AI opportunities as well as opportunities
in our eRADIMAGING, informatics and related software businesses. Sham Sokka and Sanjog Misra will be focused on commercialization partnerships,
product development and operations in our digital health platform. While they assist us with continued progress in DeepHealth, Aidence
and Quantib, Sham and Sanjog will also be launching a number of initiatives in generative AI designed to improve efficiency and lower
cost of many of our core business processes, such as contact centers, scheduling, insurance verification, front office functions, reporting
tools, revenue cycle, and many more.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generative AI should be as transformative to the
core functions of our imaging center business as clinical or predictive AI will be to the delivery of our professional radiology services
and population health screening. In the coming quarters, we will share the initiatives that we are undertaking, a number of which we have
been prioritizing to help us address the challenges of the current labor market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;m also pleased to announce that Dr. Greg
Sorensen, the founder of DeepHealth, the first AI company we purchased over three years ago, has assumed the role of Chief Science Officer
and has joined the Board of Directors at RadNet. The investments we are making in digital health technology and personnel underscore our
commitment to our digital health initiatives and highlight their growing importance to RadNet&rsquo;s future strategic direction and priorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are experiencing strong growth with our digital
health platform. In the first six months of this year, our AI revenue grew 109% from last year&rsquo;s same period, driven predominantly
by the launch of our enhanced breast cancer detection EBCD mammography offering, which we continue to implement across our networks. We
expect this growth to accelerate in the second half of this year as we expand EBCD to more of our women&rsquo;s centers throughout our
markets, particularly within our west coast operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The results of the program and the feedback we
are receiving from our patients, referring physicians and hospital partners have been excellent. Since the inception of the EBCD program,
we have diagnosed over 450 breast cancers that without the intervention of artificial intelligence might have gone otherwise undetected.
Detecting cancers sooner allows for better patient outcomes through earlier treatment and intervention and reduces cost to the healthcare
system. Furthermore, we are reducing the callback rates for patients through the use of AI by being more definitive with the initial screening
exam. We currently are experiencing approximately 30% enrolment in the EBCD mammography screening program and believe we will see greater
uptake as we improve communicating and marketing the benefits to our patients and their referring physicians.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Finally, I would like to comment on RadNet&rsquo;s
liquidity position and financial leverage. On June 16, we completed an equity offering where we raised $246 million of net proceeds to
de-leverage our balance sheet and position us to accelerate growth. This offering along with strong operating performance resulted in
a net debt to Adjusted EBITDA ratio of approximately two times at quarter end. We currently have the lowest leverage and strongest liquidity
position in our Company&rsquo;s history. As of June 30, we had $357 million of cash on our balance sheet and were undrawn on our $195
million revolving line of credit. Our days sales outstanding - DSOs at June was 35.4 days, which we believe to be one of the best in the
industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we are committed to growing and expanding
our business, we will also continue to follow our methodical and disciplined approach to managing our financial leverage. Our low leverage,
lower cost of capital and strong liquidity relative to many of our other industry operators positions us to capitalize on acquisition
opportunities and other business opportunities where capitalization is advantageous. We remain patient and disciplined in our approach
to acquisitions, focused first on our core markets where we bring unique synergies and cost savings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I&rsquo;d like to turn the call
back over to Mark to discuss some of the highlights of our second quarter 2023 performance. When he is finished, I will make some closing
remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you Howard. I&rsquo;m now going to briefly
review our second quarter 2023 performance and attempt to highlight what I believe to be some material items. I will also give some further
explanation of certain items in our financial statement as well as provide some insights into some of the metrics that drove our second
quarter performance. I will also provide an update to 2023 financial guidance levels which were released in conjunction with our 2022
year-end results in March, and which we amended in May upon releasing our first quarter financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In my discussion, I will use the term Adjusted
EBITDA, which is a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and
amortization, and excludes losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishments, and non-cash
equity compensation. Adjusted EBITDA includes equity and earnings of unconsolidated operations and subtracts allocations of earnings to
non-controlling interest and subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taking place during the period.
A full quantitative reconciliation of Adjusted EBITDA to net income or loss attributable to RadNet Inc. common shareholders is included
in our earnings release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that said, I&rsquo;d now like to review our
second quarter 2023 results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the second quarter of 2023, RadNet reported
revenue from its imaging centers reporting segment of $401.3 million and Adjusted EBITDA of $63.7 million, which excludes revenue and
losses from the AI reporting segment. As compared with last year&rsquo;s second quarter, RadNet revenue increased $48.5 million or 13.8%
and Adjusted EBITDA increased $8.2 million or 14.7%. Including our AI reporting segment, revenue was $403.7 million in the second quarter
of 2023, an increase of 13.9% from $354.4 million in last year&rsquo;s second quarter. Including the losses of the AI reporting segment,
Adjusted EBITDA was $60.4 million in the second quarter of 2023 and $51.3 million in the second quarter of 2022, an increase of 17.7%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the second quarter of 2023, RadNet reported
net income of $8.4 million as compared with $7.9 million for the second quarter of 2022. Diluted net income per share for the second quarter
of 2023 was $0.12 compared with a diluted net income per share of $0.13 in the second quarter of 2022, based upon a weighted average number
of diluted shares outstanding of 60.9 million shares in 2023 and 57 million shares in 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were a number of unusual or one-time items
impacting the second quarter, including the following: $4.2 million of non-cash gain from interest rate swaps, $1 million expense related
to the change in valuation of contingent consideration related to completed acquisitions, $759,000 of expense related to leases for our
de novo facilities under construction that have yet to open their operations, and $8.7 million of pre-tax losses related to our AI reporting
segment. Adjusting for the above items, adjusted earnings from the imaging center reporting segment was $14.9 million and diluted adjusted
earnings per share was $0.24 during the second quarter of &rsquo;23. This compares with adjusted earnings of $8.6 million and diluted
adjusted earnings per share of $0.15 during the second quarter of 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also affecting net income in the second quarter
of 2023 were certain non-cash expenses and unusual items, including the following: $4.9 million of non-cash employee stock compensation
expense resulting from the vesting of certain options and restricted stock; $1.9 million of severance paid in connection with headcount
reductions related to cost savings initiatives; $77,000 of disposal of certain capital equipment; and $748,000 of non-cash amortization
of deferred financing costs and loan discounts related to financing fees as part of our existing credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the second quarter of 2023 as compared with
the prior year second quarter, MRI volume increased 11.8%, CT volume increased 11.3%, and PET CT volume increased 18.3%. Overall volume
taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and all other exams, increased 11.4% over the prior
year second quarter. On a same center basis, including only those centers which were part of RadNet for both the second quarters of 2023
and 2022, MRI volume increased 7.3%, CT volume increased 6.3%, and PET CT volume increased 18.8%. Overall, same center volume taking into
account all routine imaging exams increased 7.1% over the prior year same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the second quarter of 2023, we performed 2,551,382
total procedures. The procedures were consistent with our multi-modality approach whereby 75% of all the work we did by volume was from
routine imaging. Our procedures in the second quarter of 2023 were as follows: 387,619 MRIs as compared with 346,598 MRIs in the second
quarter of 2022; 235,138 CTs as compared with 211,221 CTs in the second quarter of 2022; 15,036 PET CTs as compared with 12,710 PET CTs
in the second quarter of 2022; and 1,913,589 routine imaging exams as compared with 1,719,647 of all these exams in the second quarter
of 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overall GAAP interest expense for the second quarter
of 2023 was $16 million. This compares with GAAP interest expense in the second quarter of 2021 of $11.4 million. The higher interest
expense is predominantly the result of the upsized New Jersey Imaging Network credit facility completed in October of last year in conjunction
with NJIN&rsquo;s acquisition of Montclair Radiology. Cash paid for interest during the period, which excludes non-cash deferred financing
expense and accrued interest, was $17.8 million. Cash paid for interest net of interest earned on our cash balance and interest rate swap
payments received was $12.4 million for the three month period ended June 30, 2023, and $29.9 million for that same period last year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to our balance sheet, as of June
30, unadjusted for bond and term loan discounts, we had $518.9 million of net debt, which is our total debt at par value less our cash
balance. This compares with $662.1 million of net debt at June 30, 2022. Note that this debt balance includes New Jersey Imaging Network&rsquo;s
debt of $146.3 million for which RadNet is neither a borrower nor guarantor. As of June 30, 2023, we were undrawn on our $195 million
revolving line of credit and had a cash balance of $357 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At June 30, 2023, our accounts receivable balance
was $174.5 million, an increase of $8.1 million from year end 2022. The increase in accounts receivable is mainly the result of the significant
increase in our procedural volumes over the last quarter. Our days sales outstanding, or DSO remains near the lowest levels in our Company&rsquo;s
history at 35.4 days as of June 30, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through June 30, 2023, we had cash capital expenditures
net of asset dispositions and sales imaging center assets in joint venture interests of $86.9 million. This excludes $8.4 million of cash
capital expenditures at our New Jersey Imaging Network joint venture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I&rsquo;d like to update and revise
our 2023 fiscal year guidance levels, which we released in conjunction with our fourth quarter and year end 2022 results and amended after
reporting our first quarter 2023 financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For total net revenue, we have increased our guidance
range by $25 million at the low end and $10 million at the high end to $1.575 billion to $1.610 billion. For Adjusted EBITDA, we have
increased both the low end and the high end of our guidance by $7 million to $232 million to $242 million. We have left our capital expenditure,
cash interest expense and free cash flow guidance levels unchanged as amended after the first quarter results, and for the artificial
intelligence segment, due to the delay that Dr. Berger spoke about in our implementation of that program, we have lowered the revenue
guidance by $5 million both at the low end and the high end to $11 million to $13 million, and our Adjusted EBITDA loss projection for
the year has increased by $2 million at both the low end and the high end to $11 million to $13 million loss for the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In our core imaging center reporting segment,
we have increased our guidance ranges for revenue and Adjusted EBITDA to reflect the strong financial results of the first half of 2023
as compared with our initial budget. We have lowered our guidance ranges for revenue and Adjusted EBITDA for the AI segment and, as Dr.
Berger mentioned, we have been refining the EBCD program and have been testing different levels of pricing, various service offerings,
new marketing collateral, local market sales, and marketing strategies. We estimate that this optimization process has resulted in a 90
to 120-day delay in the progress of the program. Though the new revenue guidance levels fall short of our original estimates, it represents
almost a tripling of our business from 2022 levels. We remain incredibly excited about the growth in AI and we continue to believe that
we can breakeven in the AI segment before the end of 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;ll now take a few minutes to give you
an update on 2024 reimbursement and discuss what we know with regards to 2024 anticipated Medicare rates. As a reminder, Medicare represents
about 22% of our business mix.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to Medicare reimbursement, several
weeks ago we received a matrix for proposed rates by CPT code which is typical as part of the physician fee schedule proposal that is
released about this time every year. We have completed an initial analysis and compared those rates to 2023 rates. We volume-weight our
analysis using expected 2024 procedural volumes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As you may recall, three years ago CMS moved forward
with increased reimbursement for evaluation and management CPT codes which favor certain physician specialties that regularly bill for
these services, particularly primary care doctors. CMS proposed doing so with budget neutrality, meaning that it proposed to reallocate
reimbursement from physicians who rarely bill for E&amp;M codes to physicians who regularly bill for these codes. As a result, radiology
and most other specialties experienced cuts in reimbursement during 2021, 2022 and 2023, cuts meant to be phased in over a several year
period. The cuts we faced in 2023 were substantially mitigated by legislation that was passed at the end of last year as part of the Consolidated
Appropriations Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this year&rsquo;s proposed ruling governing
2024 reimbursement, Medicare appears to effectively be phasing in any remainder of the E&amp;N code related cut avoided last year as a
result of the Consolidated Appropriations Act. The cut proposed for 2024 results from a decrease in the conversion factor in the Medicare
fee schedule by about 3.4% from $33.89 to $32.75, along with certain minor changes to the RVUs - the relative value units of certain radiology
CPT codes. Our initial analysis of the proposal for next year implies that RadNet on roughly $1.6 billion in revenue would face an approximately
$7 million to $9 million revenue hit in 2024 from its Medicare business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the proposed decrease in the conversion
factor affects all physicians, not just radiologists, there are many lobbying groups from the various medical specialties aggressively
opposing the cut, including radiology&rsquo;s two main lobbying forces, the Association for Quality Imaging, or AQI, and the American
College of Radiology, the ACR. At this time, our experts believe there is a high probability that the final rule to be released in November
will be less severe than the current proposal as a result of Congressional action that could take place later this year, similar to what
happened last year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November during our third quarter financial
results call, we hope to have more of an update to give you about this matter. While the $7 million to $9 million cut to RadNet&rsquo;s
revenue next year is not insignificant, we have reimbursement increases completed or scheduled from capitated and commercial payors that
will fully mitigate this Medicare reduction, which should go into effect in the currently proposed period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;d now like to turn the call back to Dr.
Berger, who will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you Mark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Technology has always been a driver for change
in our industry. This appears to be truer today than ever before. Artificial intelligence, both clinical and generative, is in its nascent
stage within the field of radiology. Everything that we do today will be impacted by technology innovation and artificial intelligence
in the coming years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is an information technology business.
Almost every process we perform, including collection of patient information, scheduling, preauthorization, insurance verification, creation
of radiology reports, billing and collecting, medical coding, and processing the patient payments can be enhanced by data algorithms and
management tools. Artificial intelligence and informatics either already play or will play important roles in all of these business processes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet has always been on the leading edge of
technology, which has been a key to our success. In the past, we have both adopted solutions from others that benefited our business and
created our own solution in areas we felt were imperative for us to control. This philosophy has not changed. In 2010, we began a journey
to design our own radiology information system and image management system, which has become core to our data work flow. Much of what
we do at the operating level and the efficiencies we have created in operating our 363 centers have been the result of our ability to
control our IT infrastructure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we move into the next generation of innovation
driven primarily by AI, we see even more opportunity to bring efficiencies, cost savings and improved margins to RadNet through investments
in our digital health initiatives. As demonstrated by our second quarter results, our core operating business is healthy and growing,
supported by heavy and expanding procedural volumes. The next stage of RadNet&rsquo;s growth and development will be to bring these technological
solutions to our business and to the broader radiology marketplace that makes servicing this accelerating demand possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I believe we have assembled many of the components,
including the management talent to take our business and industry to the next level of innovation, elevating radiology and our diagnostic
capabilities to an even more important and critical role in healthcare delivery. We&rsquo;re excited to keep our stakeholders informed
of our progress in these areas while continuing to execute on driving growth in our core business through our focus on same center performance,
hospital and health system partnerships, tuck-in acquisitions and de novo expansion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator, we are now ready for the question and
answer portion of the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. (Operator instructions)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Today&rsquo;s first question comes from Brian
Tanquilut with Jefferies. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hey, good morning guys. I guess my first question
for Howard, and maybe Mark too, obviously the core business is strong and volume performance was really compelling. Just curious how you&rsquo;re
thinking about the sustainability of strong demand trends and your ability to maintain healthy organic growth rates going forward.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning Brian, thank you. I think the key
to sustaining our growth is really the investment that I&rsquo;ve talked about in our digital health platform. The advent of generative
AI as well as the faster and easier development of new algorithms will allow us to transform all of the processes that we use to operate
our imaging centers considerably more efficiently and with less dependence on the labor issues that we currently face, much as everybody
in healthcare and, for that matter, the general economy. We expect the growth in the imaging sector of our business to continue to grow,
but that the ability for us to scale up and perform the necessary tasks and demands that we have will be imperative for us to use these
tools that can create these efficiencies and lessen our dependence on an already overstretched or stretched labor market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we move into the latter part of this year and
certainly by the first quarter, we&rsquo;ll be able to perhaps talk a little bit more specifically about these initiatives, but as we
demonstrated in the press release that we made about a week or so ago, with the new executives added to this team, we feel that we are
in excellent position to drive this transformational change and control the processes that have allowed us to operate all 363 of our centers
on a single platform, regardless of what market that we&rsquo;re in. While I like to think that we can be proud of what we&rsquo;ve achieved
to this point, I think the best is yet to come in terms of the technological innovation and transformation which radiology and imaging
are probably better suited for than virtually any other specialty in the healthcare industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brian, I&rsquo;ll just add one other thing here.
Another key to our continued growth and success is the ability to increase our capacity, and the 12 de novo centers that we have currently
under construction, I think five of which will open by year end or should open by year end, the other seven sometime in 2024, will also
be instrumental in our ability to create the capacity that we need to better service the heavy demand that we have right now in virtually
all of our markets, where we&rsquo;re experiencing significant backlogs, which is obviously a high class problem but one that is still
indeed a problem as we try to get patients into our centers expeditiously and try to provide great service to our referring physician
community.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think the de novo strategy and driving that
level of capacity in addition to the technology advances that Dr. Berger talked about, as well as some additional technology that we&rsquo;ve
licensed that allow for shorter scan times for MRI scanning with post-processing software that allows for greater throughput and obviously
greater capacity at our centers. All these things are important to continue to be able to grow like we have been, because the demand for
imaging services is there and that&rsquo;s clear in all of our markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Understand, appreciate that.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I guess my second question, as we think about
AI, and I understand the reasons for the delay or the pushing some of the targets out, I guess two questions. As I think about&mdash;you
know, Mark, you said you think you&rsquo;ll still hit breakeven by the end of 2024. Maybe you can remind us, how does that compare to
your original outlook for the business, and then second, maybe taking a step back, how are you thinking about or where does your confidence
come from in your ability to get the AI side of the business where you want it to be in the time frame that you&rsquo;ve outlined?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi Brian, I&rsquo;ll take that one and Mark can
fill in if he thinks I&rsquo;ve missed anything, like he did so nicely just in the question before this. I think we&rsquo;re as confident
and perhaps even more confident in our AI division for two reasons. Number one, we have been successful in about 30% of our screening
mammography cases, having our patients enroll in what is increasingly being recognized as a very valuable addition to the breast screening
process, and this is&mdash;since we&rsquo;re going direct to consumer, since there is no reimbursement for AI at this point in time, this
is a different strategy than most anything that we&rsquo;ve attempted in the past, although our prior effort in this was also successful
some eight years ago, I think it was, when 2D mammography got converted to 3D mammography, and we had a similar process that we implemented
to have patients pay for this before it was reimbursed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect a similar process to unfold here, so
that the direct to consumer, we hope is just a stopgap here until it&rsquo;s adopted by not only more and more of the payors, but more
and more employees--employers, I should say, that recognize this kind of wellness screening can certainly benefit them, as well as their
employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;d like to pivot on that, that while that&rsquo;s
been a slow learning process for us, what I don&rsquo;t think will be slow will be the generative AI side of the initiatives that we have
already begun embarking on, that we think can be transformative in the way that radiology is practiced and managed. I think that in some
respects may even become more important in the short term here, given a number of the issues that I mentioned in my opening remarks with
difficulties that we have in the labor market. I think you&rsquo;ll see from us in upcoming quarters more specifics about how these tools
can be implemented, and perhaps one of the more exciting methods that the new AI tools on the generative side are capable of is that we
don&rsquo;t have to rewrite everything all at one time. We can take specific core needs that we have, like our contact centers and scheduling
and insurance verification, and focus on them as segments that we can layer on when they&rsquo;re ready, rather than have to retool the
entire platform that we have. This is a huge difference from the way that we and others have operated in the past, that gives us a lot
of enthusiasm about the impact that we can have on our operational processes here in the very near future. In fact, we hope that some
of these may be implemented as early as the first quarter of 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think what you&rsquo;ll hear more and more from
us is the continued efforts that we make, not only in our breast screening program but also in lung screening and prostate screening,
as we become more comfortable with the self-pay and direct-to-consumer marketing, as well as the initiatives to take control of our operational
processes through generative AI algorithms to not only create efficiencies but to create a better patient experience for all of our people
that choose to get their scans done in the RadNet locations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got it. Then maybe Mark, last question from me,
thank you for giving color on your view on reimbursement. Remind me, if I&rsquo;m thinking of this correctly, this is about the same level
that you see in terms of proposed cuts every year, and am I right in thinking that Congress has stepped in to kind of block or mitigate
this over the last three or four years?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, so this, we believe, is the result--the proposed
cut is the result of a phase-in of the budget neutrality aspect of increasing the E&amp;N codes that primary care docs and family practice
medicine docs bill under, which occurred several years ago, and they&rsquo;ve been phasing in this cut in not just radiology but every
specialty in order to pay for those E&amp;N increases. We&rsquo;ve faced these cuts for the last few years. It was a little bit higher
the last couple of years but then was ultimately mitigated by this Appropriations Act that was passed in December. In both December of
last year and the December of the prior year, it was a bipartisan bill that was sponsored by two Congressmen, one Republican, one Democrat
from both California and Indiana - this is Bera and Bucshon, and so a lot of our experts and lobbyists not only within radiology but within
healthcare in general, because remember this cut is being faced not just by radiologists, it&rsquo;s being faced by everybody, that there&rsquo;s
a lot of support to try to get these cuts either reversed or mitigated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have some level of confidence that again this
year, some of the proposed cut here in the Medicare communication that we got several weeks ago will likely be mitigated. But regardless
of whether it&rsquo;s mitigated or not, and we&rsquo;re estimating the total impact to be the $7 million to $9 million range in our revenue,
we&rsquo;ve got more than that in terms of reimbursement increases that have either already gone into place in 2023 that will increase
our reimbursement in 2024, or that will be scheduled to go into place both within our capitation contracts, as well as our commercial
contracts. Regardless, we&rsquo;re not overly concerned about this level of reimbursement cut, but we do have some level of optimism that
part of the Medicare cut will be mitigated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brian, let me add one other thing, which I&rsquo;m
sure you&rsquo;re aware of, which may make the drive away from hospitals even stronger than it is right now. As I&rsquo;m sure you&rsquo;re&mdash;as
you&rsquo;ve seen, that the new hospital outpatient prospective payment system has increased the reimbursement to hospitals for their
Medicare patients, further widening the reimbursement that&rsquo;s paid for hospitals for the same services that we provide on a freestanding
outpatient basis. I think it&rsquo;s interesting to see that the very thing that has been a big driver in moving the patients away from
hospitals into outpatient centers, which was primarily from the commercial payors, in the extraordinary difference in reimbursement is
now being seen also on the Medicare side of it, and in the times that we exist with inflation and expenses going up, it will be even more
imperative for our patients to be very mindful of where they get their place of service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To that point, Brian, the HOP schedule now has
over a 30% premium relative to the outpatient Medicare fee schedule, which makes no sense whatsoever, particularly because Medicare supposedly
is interested in site neutrality with respect to its reimbursement. As this spread widens, I think you&rsquo;re going to have more and
more Medicare patients, particularly ones that have a 20% co-pay, which is very typical in the Medicare fee-for-service landscape, start
directing their business out of hospitals, just like the private payors and commercial insurance plans are doing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got it, thank you guys.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Our next question today comes from
Nathan Malewicki with Raymond James. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nathan Malewicki</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hey, you&rsquo;ve got on Nate here, stepping in
for John. First on the labor environment, last we heard, contract labor costs were running at about 50% of last year&rsquo;s levels, so
any update on contract labor and anything you can quantify there? Just more broadly on the labor environment, has that and will that continue
to improve in the second half and then in the foreseeable future?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure, hi Nate, I&rsquo;ll take this one. What
we&rsquo;ve said in the first quarter, what we did say in the first quarter is that our reliance on contract labor as well as our reliance
on paying our own employee base overtime is about at 50% of what it was last year. It&rsquo;s not that the cost of outside labor, of these
staffing companies has gone down by 50%, it&rsquo;s just that we&rsquo;re relying less on them as we&rsquo;ve become more successful in
filling open positions. If you remember, our number of open positions hit its height in September of last year, and throughout last year
we were mightily struggling with filling staff at our facility&mdash;at the facility level and keeping our centers open long enough to
service the heavy demand. We&rsquo;ve been much more successful this year and there has been some stabilization in general in the labor
market in being able to staff our centers appropriately, to keep the centers open to fill more of this backlog.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It&rsquo;s not that the pricing has gone down,
it&rsquo;s just our reliance on outside services that&rsquo;s gone down.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nathan Malewicki</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got you, thanks for that.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Then just on seasonality here, is it safe to assume
that this year features kind of similar trends as pre-pandemic periods, so maybe, I don&rsquo;t know, 24%, 25% of total EBITDA in 3Q and
then a bit of a step-up there in 4Q?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, we typically do see seasonality in our business.
The first quarter tends to be our most challenged quarter primarily for two reasons, first being winter weather conditions in the northeastern
United States where roughly 35% of our business is, and we&rsquo;re impacted by storms that close facilities or power lines going down,
power outages, things of that nature. The second reason the first quarter is a little slower is the reset of patient deductibles tends
to create a phenomenon where patients utilize healthcare services less at the beginning of the year and then are more liberal with their
spending as they move through their deductibles towards latter parts of the year. We tend to see the first quarter and the first half
of the year a little lighter than what we see in the third and fourth quarters. Also, summer vacations tend to impact the second quarter,
and in the fourth quarter as patients have moved through deductibles, tends to be a high utilization quarter, and then you also have higher
utilization of mammography in the fourth quarter which coincides with the October month, which is breast cancer awareness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I would expect, all things being equal, although
we can never really tell, that the second half of the year tends to be stronger than the first half, and 2023 should be no different.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nathan Malewicki</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Awesome, thanks. Then just to squeeze in one more
here, on the equity earnings of joint ventures line, it looks like that came in lighter than our model, and it was about $1.5 million
this quarter, kind of a bit of a deviation from historical trends. Anything to read through there in terms of JV consolidation or just
the overall JV strategy, and then just how to think about that line item moving forward? That&rsquo;s all I&rsquo;ve got, thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, nothing I can think of that would be a trend.
Obviously one quarter, a trend doesn&rsquo;t make, so I would expect that line to even out. I have to go back to see what impacted the
quarter in that respect at our unconsolidated JV level, which is what you&rsquo;re talking about in terms of equity and earnings, but
yes, I wouldn&rsquo;t&mdash;there&rsquo;s nothing that&rsquo;s gone on there that would make that sustainable, that change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, and our next question today comes from
Yuan Zhi with B. Riley Securities. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Yuan Zhi</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning. Congrats on another strong quarter,
and thank you for taking our questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">First, a follow-up on Brian&rsquo;s question,
maybe more for Mark. I noticed the same center volume year-over-year growth rate was 7.1% versus 9.3% last quarter. The overall volume
growth was 11.4% versus 14% last quarter. This might be a repeat from the last question, but especially for your 2023 guidance, your modeling
assumptions, do you anticipate the volume growth in the second half to be similar to what you have observed in 2Q, and it would be great
if you can comment on what you have observed so far regarding the patient flow in July. Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure, sure. Thank you Yuan, nice to talk to you.
We have had very strong same center performance for the first half of the year. We&rsquo;ve always said historically that we felt over
the long run, given the growth in the industry and our growth in our markets and taking share away from competitors, that we felt that
we could sustainably grow in the 3% to 5% same store sales growth over the long period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As there has been significant growth not only
in the industry from some of the newer technologies, such as PSMA that Dr. Berger spoke about on the prostate side, and other things that
are driving new applications and new indications for ordering these tests, the industry has been growing nicely and we&rsquo;ve been growing
faster, because we&rsquo;re also benefiting from the shift in hospital-based&mdash;from hospital-based outpatient imaging to freestanding
center imaging. Our growth over the last year or two has been exceeding that kind of 3% to 5% range that we&rsquo;ve talked about.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Now, in the first quarter, we had extraordinary
growth, as you mentioned, at 9.3%, and we talked about it then and I&rsquo;ll emphasize this now, we don&rsquo;t believe 9.3% is necessarily
a sustainable number. We were impacted positively by two things in the first quarter that was extraordinary, the first being that we had
a much more mild winter this year relative to the winter in the first quarter of 2022, and that benefited us in the first quarter. The
second extraordinary impact was that the first quarter of 2022 was impacted by the omnicron variant of COVID, where not only patients
were impacted extensively but our employee base was also impacted, to the tune of having over 8% of our employee base on COVID leave for
the first couple weeks of January of last year. The 9.3% this year in the first quarter was better than it normally would have been but
for those two situations that I just described.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The second quarter here was a much cleaner, what
I&rsquo;d call same store sales comparison with last year, where we weren&rsquo;t being impacted by weather, we weren&rsquo;t being impacted
by omnicron in 2022, and it was, I think, a more fair comparison. To your question directly about the second half of the year, I would
hope that we could exceed or be towards the high end of that 3% to 5% growth&mdash;you know, same store sales growth that we&rsquo;ve
talked about in the past, and would hope that it would look more like the second quarter going forward because of all the reasons that
I&rsquo;ve talked about, which is driving our growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Yuan Zhi</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got it. Maybe a quick follow-up there, it would
be great if you could comment on what you have observed so far of the patient flow in July.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">July was a good month for us. July is always a
bit of a challenge, given the July 4th holiday and what day of the week it falls on, which this year it fell on a Tuesday, which is not
necessarily most advantageous for us given that the Monday is almost like an extension of the holiday weekend, and also the vacation schedule.
But relative to last year&rsquo;s July volumes, we&rsquo;re pleased with what the early results in July look like and where August appears,
at least for the first week, it appears to be also holding well within our expectations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Yuan Zhi</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got it, thanks for the additional color there.
Maybe Howard or Mark, can you provide more color on your capacity right now for MRI and PET scans, the current procedure close to 90%
of your capacity? I&rsquo;m asking because the comments from Biogene and (inaudible) that are targeting to treat 10,000 Alzheimer disease
patients by the end of March 2024. Assuming there is this increasing demand, I&rsquo;m curious what do you view as the rate limiting factors
for you to meet this demand, such as the numbers of imaging instruments you have, the staffing to support the procedure, or even the supply
of imaging agents. Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Great question. I&rsquo;ll be happy to answer
that one.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The demand that we have is not exceeding the capacity
of our equipment, it&rsquo;s exceeding the ability of us to staff up to levels that allow us to use our equipment on the extended hours
and times when we can see these patients. That&rsquo;s our biggest challenge and it&rsquo;s particularly apparent in the MRI modalities.
What we&rsquo;re doing to address that, which again is somewhat novel to the RadNet core strategy and platform, is that there is new technology,
called remote operation command centers, that allow a technologist to operate more than one MRI piece of equipment remotely, and what
we have found is that in certain markets, for example in Florida or in Arizona, where the shortage is not as serious as it is, let&rsquo;s
say in New York, we are gaining better acceptance and hiring of technologists that can run those systems remotely from other of our markets.
That is probably the near-term ability for us to address some of these additional capacity issues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As Mark mentioned, we&rsquo;re also building more
centers to add capacity, and in some cases we have begun to buy our own mobile scanners that allow us, particularly more so on the west
coast, to move those around to areas that are being particularly challenged. We do have a lot of tools in the tool kit, not the least
of which also is that the newer MRI scanners or upgrades that we can make to existing scanners have had a remarkable impact on reducing
the scan time, which for many of our MRIs has been reduced from 20 to 30 minutes down to 10 minutes or, in some cases, even less, has
allowed us to increase our throughput at capacity in that manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There&rsquo;s a number of ways to address these
problems, and all of it by and large is really driven by the use of technology, both from an artificial intelligence standpoint and some
of these other remote tools and other algorithms that just help us increase our capacity without necessarily having to increase our staffing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">And Yuan, I&rsquo;ll address the second part of
your question, which was specifically about Alzheimer&rsquo;s imaging and what you&rsquo;re hearing out of Biogen and Lily and others.
The initial PET CT, which is one of the key ways of detecting the presence of these amyloid plaques, which is necessary to get these patients
onto the newer therapies that have come out by some of these pharmaceutical companies, that could be a huge opportunity for diagnostic
imaging and obviously for us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to capacity, which I think was the
question that you had asked as it relates to Alzheimer&rsquo;s imaging, we currently have 67 PET scanners that are doing on average&mdash;well,
doing in total 60,000 scans per year, give or take. When you do the math over 255 workdays, each PET CT scanner that we have is doing
less than four PET CTs per day. The rest of the day, those scanners are very busy doing routine CT work. If we had--if there were a flood
of PET CT demand in relation to these Alzheimer&rsquo;s drugs, what we would do is to utilize our existing PET CT capacity and each PET
CT&mdash;a busy PET CT can be doing 13, 14, 15 scans a day, so we have a lot of PET CT capacity in our existing installed base. The challenge
we would have at that point is then moving routine CT work to either other scanners, expanding hours, or having to buy additional CTs
to take over that level of volume, but we do have a fair bit of PET CT capacity even within our own installed base at this point.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Yuan Zhi</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got it. Appreciate all the helpful color there.
Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, and our next question today comes from
Mitra Ramgopal with Sidoti. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, hi. Good morning. Thanks for taking the questions.
Most of mine have already been answered, but I just had a quick one in terms of the cash on the balance sheet in light of the equity raise.
How should we think of the capital allocation priorities in terms of growing the Company via M&amp;A, de novos, investments in technology
and personnel versus maybe looking to reduce debt, given the high interest rate environment?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I would say all of the above might be the best
way for me to answer that, Mitra. I think one of the benefits of the equity raise that we accomplished was giving us the opportunity to
look at ways that we could deploy that capital in the best interests of the Company&rsquo;s growth. As we said, one of our shorter term
possibilities is the pay down of some of our debt, but given the Company&rsquo;s projected cash flow for the rest of this year and next
year, I think you&rsquo;ll find that we&rsquo;ll be investing in the de novos, upgrading technology of existing equipment, replacing older
equipment with newer equipment. We used to use in the past operating leases as a way of minimizing the amount of cash outlay. We have
essentially eliminated that and now are (inaudible) cash for virtually all of our capital equipment investment, so I think that will also
help our margins and help the growth of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 51px; width: 840px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lastly, we are looking to use the capital we raised
to invest in our new digital health initiatives, which we think may have the best returns on investment given the long term prospects
that we&rsquo;re tending towards a capital light business that can have substantially better margins than the imaging center sector. We&rsquo;ll
look to continue to utilize our capital in any way that can help the business grow, and we&rsquo;ll look forward to discussing some of
those with more detail as the rest of this year unfolds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When we completed the equity offering, because
you can imagine prospective investors were very interested in this very question, what we said was part of the reason why we were raising
the money was that in October of this year, one of our interest rate swaps rolls off and gives us more exposure to floating rate debt,
and we intend&mdash;and that&rsquo;s $100 million of notional exposure that rolls off in October of this year, and so our intention is
to take $100 million from our cash balance at that time and repay debt, so that we don&rsquo;t have more floating rate exposure. That&rsquo;s
still our intention to do that, and the only reason why we wouldn&rsquo;t do that is if there were some extraordinary use of proceeds
before that time, like an M&amp;A opportunity that would take its place, but that&rsquo;s not the intention in terms of utilizing it for
M&amp;A at this point. There&rsquo;s nothing that&rsquo;s a foregone conclusion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, and congrats on a great quarter again.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Ladies and gentlemen, this concludes
our question-and-answer session. I&rsquo;d like to turn the conference back over to the Management Team for any final remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Again, I would like to take this opportunity to
thank all of our shareholders for their continued support and the employees of RadNet for their dedication and hard work. Management will
continue its endeavor to be a market leader that provides great services with an appropriate return on investment for all stakeholders.
Thank you for your time today, and I look forward to our next call. Good day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you sir. This concludes today&rsquo;s conference
call. We thank you all for attending today&rsquo;s presentation. You may now disconnect your lines and have a wonderful day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide
an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference
call. This transcript is being made available for information purposes only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>rdnt-20230804.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaaJCaPty552WYkxvmR2fWm6DyEoGiAu7iBY0pg2YZ0D -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:RDNT="http://radnet.com/20230804" elementFormDefault="qualified" targetNamespace="http://radnet.com/20230804">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://radnet.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20230804_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20230804_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>rdnt-20230804_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>rdnt-20230804_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20230804.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" #B @\# 2(  A$! Q$!_\0
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M/!7@I/ NG?88;R]NK&,@6Z7,AEDMU'1 Y^9@. -V6XY)ZUOT %%%% !1110
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MZ+ZG^M>N_#OX,Q^+-3^U7BG[#"V2,?ZT^G^)KVN&.'3+)458X88$& /E5 *
M*/A+PCIO@?0X-.TFS@L+*W 6.*)-JC_Z_J3R:H^+/B7I7@X;;JX#3$?+$AW.
M?\/QKS?XG?M*K<F:P\.RK)L8QR7B\C(Z[/7'K7FND23:KJGF2227$TQ^9F.Y
MF- 'L/B_XRWC^%;BZM%^Q]HR?F;Z^E? 7[67Q*U[QE=7-O)J&I7QD.!"LK,&
M/;"CC]*^_P"S^#4GBOP_#;WDLEK WS.%'SL/Z5T'@SX">$_ C"6QT6S%UU:Y
MEC$DI/KN.<?AB@#\+_$O[!/QG^.DC-X=\!Z_<Q3'Y9Y83%$?^!-@?C7 >+O^
M#=G]J#QBC-#X5TF'S,D";5H%8?7YJ_I 1%0?+BG9H _E/^)W_!M-^U]H-O)=
M6O@6VOO*RV++5X'D./0!LFN!T#Q%_P %!_\ @EMJJWT,7Q@\,Z=:L%,-]!-?
MZ<RCMLD#J!V^7'UK^N[-5[NPAOX&CGCCFCD!#(ZAE8'L0>#0!^,/_!,__@Z#
MU3X@QV.@?';PK'I]]\L4FM:5&RJ">-TMNV67'?:3SVQ7[ ?#'XL>'_C+X2M]
M<\-:M9ZQI=XH:*>VD#J?8^A]0:\A^//_  2\^!W[0ADFUCP#HMGJDF2NH:9
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M8/\ A]I_B;QY>7-GIVIWRZ=;B"$S2/*4=\8';:C<U\TK_P ''_[.)_YBFO\
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M&\2VCJI^5[Z4*\Q/;*J43V*M7T[_ ,$H/@&OBBZ;7[Z'=I^CX"!AQ+,>0/\
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MG_!)<;O^"C_P9!Z?\)79?^C!7@?B7_D/WG_7>3_T(U[Y_P $E_\ E)!\&?\
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M#1#IR.V/2NH\&>-])^(?AVVU;0]2LM6TV[4-%=6LHEBD'L10!L4444 %%%%
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M'_HA:M?"S.3?,EZGHG_!8/\ :)\:_!'XB^#[7PKXBU#18+[3II)TMWVK*RR
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M?PQ>:1I64ZI$"QZ*NJ7:J/P4 ?A7SC_P6J^*5QXI_:4T_P -+)_H/AG38V*
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M;KA?K7V-_P %^/\ E*E\2/\ =T__ -(8*^.;/_CY3ZU^4Q_Y'"_Q_JC^S/\
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M._\ )%]4_P!Z'_T:E?T.?LH_\FQ?#O\ [%K3O_26.OYX_P!IW_DB^J?[T/\
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M\ZCS(V]"5/S*17M6: ,W0->35[90W[NZ11YL).&0UI9K@OC3\.-2\3:3]O\
M#MXVF^(;,;K>53A9?]A_4&OGK0_^"HEE\)O&#>%_BYI-UX;U&!MC7Z1$PMC^
M-EZX/JN10!]A9I'^X?I7-?#7XO>&?B_H*ZEX9U[2M<LW /FV=PL@3/9@"2I]
MC@UTCM\K?2@#^:7_ (+[<?\ !5#XD9_NZ?\ ^D,%?'EI_P ?4?UK],/^"S'_
M  3F^-GQY_X*)^.O%/A'X>:YKF@ZFME]GO+?R_+FV6<2-C+ \,I'2OF33/\
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MZC@=Q7[*L/Y5=3H9T^OJ?!O_  7;/_%M_ /_ &$[C_T4M?FC)]PU^K'_  6
M^!/B[XY>!_!EMX3T.\UJXT_4)YKA8,9C5HU4$Y([U\&_\.^?C-_T(.L?^0__
M (JH-#H/^"8_[<<7_!/;X+:YX3FT*3Q$^L:[-K(N$G\CR_,CC39C!Z>7USWK
MZ3_X?M6W_0@S?^!X_P#B:^3?^'?'QF_Z$/6/_'/\:3_AWS\9O^A!UC_R'_\
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M10 ;?:F^6OI3J* &K$%%.(R*** &^4*/*%.HH ;Y0H5-M.HH **** "BBB@
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M4+75M%UBUCO+*\MI!)#=0NH975@>00: -JBBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
;!1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (1 ML# 2(  A$! Q$!_\0
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M^_"?X4?\+8\2_P#/Y'_WX3_"@#WNBO!/^%L>)?\ G\C_ ._"?X4?\+8\2_\
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M1_PMCQ+_ ,_D?_?A/\* />Z*\$_X6QXE_P"?R/\ [\)_A1_PMCQ+_P _D?\
MWX3_  H ][HKP3_A;'B7_G\C_P"_"?X4?\+8\2_\_D?_ 'X3_"@#WNBO!/\
MA;'B7_G\C_[\)_A1_P +8\2_\_D?_?A/\* />Z*\$_X6QXE_Y_(_^_"?X4?\
M+8\2_P#/Y'_WX3_"@#WNBO$_#_Q.\0:AKVFVLUU&T,US'&ZB%1E2X!YQZ&O;
M* "BBB@ KY_^*7_(]ZG_ -LO_125] 5\_P#Q2_Y'O4_^V7_HI* -3POX7TS4
MM"MKBXMO,F?=N;S&&<,0. ?05J_\(3HO_/E_Y%?_ .*H\$_\BQ9?\#_]#:MR
MNR,59:'ESG+F>IA_\(3HO_/E_P"17_\ BJ/^$)T;_GS_ /(K_P#Q5;E%5RQ[
M$>TGW,'_ (0O1O\ GS_\BO\ _%4?\(7HW_/G_P"17_\ BJWJ;C%'+'L3SS[L
MP_\ A"]&_P"?/_R*_P#\51_PA>C?\^?_ )%?_P"*K;HHY8]A^TEW,+_A"]'_
M .?/_P BO_\ %4?\(7HW_/G_ .17_P :W::11RQ["YY]V8G_  A>C?\ /G_Y
M%?\ QH_X0O1O^?/_ ,BO_C6W11RQ["]I/NS#_P"$+T?_ )\__(K_ .-)_P (
M;H__ #Y_^17_ ,:W:3%/ECV#VD^[,/\ X0W1_P#GS_\ (K_XT?\ "&Z/_P ^
M?_D5_P#&MJBCDCV#VD^[,7_A#='_ .?3_P BO_C3?^$.TC_GT_\ (K_XUN44
M<L>P>TGW9A_\(?I'_/I_Y%?_ !H_X0_2/^?3_P BO_C6UC%)3Y8]A>TG_,S%
M_P"$/TC_ )]/_(C_ .-)_P (?I'_ #Z?^1'_ ,:VZ0K1RQ["]I/^9F+_ ,(?
MI'_/I_Y$?_&F_P#"(Z3_ ,^G_D1_\:VZ2GRQ[![2?\S,0^$=*_Y]?_(C_P"-
M-_X1+2O^?7_R(_\ C6X132M'+'L+VD_YF8G_  B>E?\ /K_Y$?\ QH_X1/2_
M^?7_ ,B/_C6R13:?+'L3[2I_,_O,;_A%=+_Y]?\ R(_^-'_"*Z7_ ,^O_D1_
M\:V*3%'+'L+VE3^9_>8I\*Z9_P ^W_D1O\:3_A%],_Y]O_(C?XUM4QEI\D>Q
M/M*G\S^\QSX7TW_GV_\ (C?XTG_",Z;_ ,^W_D1O\:UZ0BGR1["]K4_F?WF/
M_P (SIO_ #[?^1&_QH_X1G3?^??_ ,?;_&M8BFD4^2/87M:G\S^\R?\ A&].
M_P"?;_Q]O\:0^&]/_P"??_Q]O\:UJ0BCDCV%[:I_,_O,?_A'=/\ ^??_ ,?;
M_&D/AVP_YX?^/M_C6L5IA6JY(=B?:U?YG]YE_P#"/V'_ #P_\?;_ !IO]@6'
M_/#_ ,?;_&M0K32*/9P["]M4_F?WF;_8%C_SP_\ 'V_QIAT&R_YX?^/M_C6I
MBDI\D.Q/MJO\S^\RO[#LA_RQ_P#'V_QIIT2S_P">/_CS?XUJ,M1E:?LX=D3[
M:K_,_O,[^Q;/_GC_ ./-_C3?[&M/^>/_ (\?\:T2*:13]G#^5$^VJ_SO[V9Y
MT>T_YY?^/'_&FG2+3_GE_P"/'_&M BFE:?LX?RH7MZO\[^]F>=)M?^>7_CQ_
MQI/[+M?^>7_CQ_QK0(IC+3]G#^5"]O6_G?WLHG2[;_GG_P"/'_&F?V;;_P#/
M/_QX_P"-7Z0K5>SA_*B/;UOYW][*!TVW_P">?_CQI/[.M_\ GG^IJZ5IA%'L
MX?RH7MZW\[^]E/\ L^#_ )Y_J:3[!!_<_4U<(II%/V=/^5?<3]8K?SO[V4S8
MP_W/U---G%_<_4U<*TTBJ]E3_E7W$O$5_P"=_>RI]CB_N?J:0V<7]W]35EEI
MM'LZ?\J^XGZQ7_G?WLK_ &6+^[^II#:Q_P!W]35@K3:KV5/^5?<3]8K_ ,[^
M]E?[-'_=_4TTVZ?W?UJR5II%'LJ?\J^X7UFO_P _'][*_DIZ?K1Y*>GZU*RT
MVG[&G_*ON)^LU_\ GX_O9'Y*^E)Y2^E2TA6CV5/^5?<+ZS7_ .?C^]D+1#TI
MNP>E3TUEI^QI_P J^X7UJO\ \_'][(MH]*0J*>1BDI^QI_RK[B?K.(_Y^/[V
M,VBC:*>13:?L:7\J^X7UK$?\_'][$VBDVTZBE[&G_*ON#ZUB/^?C^]C**=BF
MT_8TOY5]POK6(_Y^/[V%)S2T4_8T_P"5?<+ZUB/^?C^]C<FC)]:4K3:/8T_Y
M5]P?6L1_S\?WL3<?6C<?6EII%'L:?\J^X7UO$?\ /Q_>R:TO9K&ZAN8'V30N
MLB-@'# Y!P?<5VWAWXE>)+[Q!IEM/J.^":ZBCD7R(QE2X!&0OH:X.M;PC_R-
M>B_]?L/_ *,6HE1I\K]U?<:4\5B'4BG4>ZZL^FJ***^:/T,*^?\ XI?\CWJ?
M_;+_ -%)7T!7S_\ %+_D>]3_ .V7_HI* .H\$G_BF;/_ ('_ .AM6[6#X+_Y
M%FS_ .!_^AM6X#7='X4>/-^^_4=1115$!1110 A6FT^DQ0*PVBEI* $*TE.H
MQ0 VBBB@04TK3J* &44XBFU6X!2%:6BEL(913B*2F A%-IU%,D;2%:<5I* &
M$4TBI*:10(C*TE2%::13)(RM)3Z0BF(C9:81BI:0BF214A%/9:2F21E:;4I6
MFD4 1E::14E)3)(F6F$5,1366JN20D4TK4I%-*TQ$=-9:D(IM!-B)EIA%3D4
MQEIW)L0D4TK4I7%-*U1)$132*E(II%,DB9:9BIBM-*YIDV(J:RU(5I*=R;$)
M%-(J9EIA%421%::14I6FD4$D1%-9:E(II6J)L0T8J0K3"M!%AE)3Z:5JKDV&
M$4UEJ2D*TR2'%)4I%,9:9(TBFTZB@0S%,*U(115"(:*>RTV@0TBDIU(5IDB4
M444 -*TE/I"*9(VD(I:*!#:2GTTB@!I6M7PC_P C7HO_ %^P_P#HQ:RZUO"?
M_(U:+_U^P_\ HQ:F?PLTI?Q(^J/IBBBBOE#],"OG_P"*7_(]ZG_VR_\ 125]
M 5\__%+_ )'O4_\ ME_Z*2@#I_!?_(LV?_ __0VK;K#\%G_BFK/_ ('_ .AM
M6Y7='X4>/4^-BTH--HJC,?12!J6@84444 %-(IU% #**<5IM M@I"M+10&XV
MBG$4V@04E+10 TBDI](5IW ;1110(:124^D*T7 ;2$4M%4(;13J:10(:5II%
M24F*!$1%-(J4BFD4]A$=(13RM)02,IK+4A6FTQ$5)4I6F%:9-B,BFE:EII6F
M(CI"M/(I*9-B,BF,M38II%,1"132*E9::13)(B*2I"*:5IB(V6HV6IJ0K038
M@(II%3,M,(JB"(K32*E*TTBF21$4QEJ8BFD4Q$-(14I6F%:HEHB9::14U,9:
M9)$132M2D4TK3)L1;::14I%-(IW)(66FU,132M,EHB(I*>1BDID#"*:13R*2
MJ)(F6FU,13"M,FQ'2%:<5I*"1M(5S3Z;BF(C*TVI::RTQ#*:13Z2@D;12E:2
MF E(13J*!#**<5IM,0A6M3PE_P C5HW_ %^P_P#HQ:S*U?"?_(U:-_U^P_\
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MBLK%:OA/_D:=&_Z_8?\ T,5$_A9K2_B1]4?2=%%%?+'Z0%?/_P 4O^1[U/\
M[9?^BDKZ KY_^*7_ "/>I_\ ;+_T4E '1^#?^1;L_P#@?_H;5M5B^#?^1;L_
M^!_^AM6U7?'X4>+4^-^HH:G4RC-60/HI,TM2 4H:DHH =130:=0/<*<&IM%
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M*2OH"OG_ .*7_(]ZG_VR_P#124 :_A7_ ) -K_P+_P!#-:X:L;PJW_$BM?\
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MX&G4VB@8ZEI :*!C@:6F4H:IL,=1111<!P:EIE*#188ZBBBD 4X&FT4 .HI
MU+0/<6E!IM% ;#Z*:&IU PHHHH *:5IU% #**<124"V$I"M+10&XVBG$4V@0
M4444 -*TE/I"M.X#:*** &E:2GTA%%Q#:"*6DJA#:*=32*!#2M-(J2DQF@1&
M132*D(II6@0RFE:>5I*9(RFLM2%:;3$18I*E(IA6F388132M24TK3$1TA6GD
M4E,5B,BF,M38II%,DA(II%3,M,(IDD16DJ0K32M,1&RU&RU-2$4$V("*:14S
M+3"*H@B*TTBI2M-(IBL1$4UEJ4BFD4R2&DQ4I6F%:9+1$RU?\._\C#I?_7U%
M_P"ABJE7O#R_\5!IG_7U%_Z&*)?"QT_C7J>Y4445\^?;A7S_ /%+_D>]3_[9
M?^BDKZ KY_\ BE_R/>I_]LO_ $4E %SPV?\ B36__ O_ $(UJ UD>'?^0/;_
M / O_0C6HK5ZT%[B/F:O\27JR6ES3 :4-5&9(#3@U14X-2*)*<K5'NIU $N:
M*C#4\-2*'YI:92AJ11(#3@U1TH:D,E!I:C!IP-(H?2AJ:&I:!CJ*;FG9H 7-
M.S3**10^BD#4M( IP--HI[C'T4T-3JD HS110 ZBFTH:@8M+FDHH ?FBF4X-
M0%Q:***!A1110 TBDI](5H%8;1110%Q"*2G4A6@+"4444"$I,4ZBF RBE*TE
M/< II%.HI;"&44XK3:8A"M)3J*8AM-*T[%% $9%-(J4BFD4$D6*2I"*:5IB&
M8I*?32M,0QEIE2TA6F218S32*D*TE,DB*TE2%::10(85II7-24A%,1"5II%3
M$4QEJB;$1%-(J0BFD4Q#*:RT\K24$V(66FD5.5J-EIW((B*:5J0BFE:HFQ&5
MII%2$4A%,1"RU>\/?\C!IG_7U%_Z&*JD5=\/K_Q/M-_Z^8O_ $,4I?"RH+WU
MZGMM%%%>"?9A7S_\4O\ D>]3_P"V7_HI*^@*^?\ XI?\CWJ?_;+_ -%)0!/X
M?_Y!$'_ O_0C6F#65H'_ ""8/^!?^A&M(-7KT_@1\O6_B2]62AJ>&J$-3@:L
MSN3!J6HE:G@TACP:<#3,TM(JY)FEJ,&G!J0R16I]14H:D5<ES2TP-2TAC\TX
M&F TM(9(#3@U1!J<&I%$M%,!IV:"AP:EIM - #J4&DHI#'T4VE!I#%I<TE%,
M8ZEIE.#4K +1112 4&EIM% [CJ*,T4 *#3J92T .HI :6@84444 &*;3J* &
M44I6DH$%-(IU% ;C:*4K24""D(I:* &44^FD50"48HHI"&XI*?2%:=P&TA6E
MHIB&TE/(IM AI%-*U)32M B,BFU*132*8B/%-J0K24$C*8RU(5I*H1%2%:D9
M:9B@D8132*DI"*8B.FD5(5IM,FQ&5IA%3%::13N(A*TTBI66FD51)%13R*:5
MH%8C9:C*U/366G<BQ 132*F9:813)(B*O: O_$^TW_KYC_\ 0Q50BKN@C_B>
MZ=_U\Q_^A"E+9E0^-'M%%%%>&?8A7S_\4O\ D>]3_P"V7_HI*^@*^?\ XI?\
MCWJ?_;+_ -%)0!)H+?\ $J@_X%_Z$:T:RM#;&F0?\"_]"-:2M7L0^!>A\I6?
M[V7JR3=3@:9FBK(N2@TY6J(&G!J!DP-.#5"&IZM4V*)*<&J,&G4AD@-+4>:<
M#2*'YIZM48-+2&2TH:HU:GYH*'TH:HZ=FD,D!I0:CIP-(9(&IU1AJ<#2*'4X
M&F4M QU%(&I:!BAJ=3*7-*PQU%&:*0"AJ=3**8Q]%)FEJ0"E#4E% #J*;FG4
M#"E#4E% #Z*;FG9H&%%%% !2$4M% #:2GTTB@0E&*** &T4ZD*T )1110(0B
MFT^DIW ;12D4E,!"*2G44A#**4BDJA"$4E.I"M AN*:13Z*!$16FD5*5II6@
M1'2$4\BFD4Q#*0C-/I"*9)$RTE2TUEIBL1%::14E)BF21TF*>132M K#"*:R
MU)2%:9)"132M3%:85JA6(B*;4I%-(IDD9&:8RU*124$V(",5<T%?^)YIW_7S
M'_Z$*@9:M:&O_$\T[_KYC_\ 0A1+9CA\:/8Z***\0^O"OG_XI?\ (]ZG_P!L
MO_125] 5\_\ Q2_Y'O4_^V7_ **2@!NBG_B6P_\  O\ T(U?!K.T8_\ $MA_
M'_T(U?!KVJ?P+T/DJW\6?J_S)5:I U5P:>K51E<FI0U1JU/I%W'@TX&HP:<#
M042JU/!J -3PU(=R4&EI@;-.#5)0\-3@U1TH:D,EI0U1@TX&CT&2AJ6HJ<K4
MBB0-3J92@TACPU.!J.ES2*)0:<#40-.#4ADE&::&IU!0[-%-I0U "TX-3:*0
MQ]%-!IU+884H:DHIC'T4W-+FD M%%%(!0U+3:4-0.XM%%% 6'!J6F4N: N.H
MHHH&%%%% "%:;3Z*!6&44N*2@!"*2G44 -HHQ10(*:5IU% #**=BFU0!2%:6
MBEL(913Z;BF E-Q3J*9(VD(IQ6DH 8132*DI"*!$16DJ0K32*9)&5I*?28IB
M&%:85Q4E%,DBII6I&6FTQ$96DJ0BFD4"&$4TBGXI*9)$RTPBIB*:5JKB(2*0
MK4A6FE:9)'5S0U_XG6G_ /7Q'_Z$*JD5<T3_ )#6G_\ 7Q'_ .A"IELQP7O(
M]=HHHKQCZP*^?_BE_P CWJ?_ &R_]%)7T!7S_P#%+_D>]3_[9?\ HI* (='/
M_$OB_'^9J\#6=I+?\2^+\?YFKP->W3^"/H?(5_XL_5_F2@TX-40-.#59D2@T
M]6J$&G TBB<-2U"K5(K5)5R0&G!JCI0U!1*#3E:H@:<#2&3 T[-0JU/!I%$E
M*#3 U+2*N2!J=48:G TACPU/#5%2YI#N2TX-4:M3J10^E#4P&G4ACP:<#48-
M*#042YI:C!IP:D,<#3J;10,=2T@-% QP:EIE*&J;#'4444 ?-7[=7[2?B[]F
MGP#X8U?P;INCZGJ>K:RNF-#K$4DD>UHI&&W9+'AMRJ,DXP37BGC3]K']KOX*
M:#)XN^(_P:\)V_@ZREB6^FT^\7S5#NJ+ADO9BN68+N,9&6%:O_!6VVDO/A-\
M/+>*9K:67Q7%&LR=8R8)@&'(Y'7K7S[^T=\#/&GP+\9^$+7XV?%7QQ\2/@KK
M%XL-[?6^HW"M!,OS!9()I)E[;A@[BJOMPRX.$F[NQVTXQ<5<_4'2?BMX:OOA
MGHGCR^U6TT'PYJNGV^I1WFK7"6T<<<T:R('9R%4X8=35_P '_$+PM\0K.6[\
M*^)='\36L+!))]'OXKM$8YP"T;$ \'KZ5\9?MGZMX:N/$WP#^&GAKP?X8UZ;
M4L?\(]=>)+JY.BV,($4<6;>*0+<90 +Y@8 8 #;S7F?[(NC:M\/OVY_C9H.F
MZCHNJZA9^#YW5?#%A'8Z:UXK6)6..VC.Q3&[O&>Y8.3@LU5S:V,O9IQYC[E^
M,7QZ\/?#[P=XY_LSQ+X=N/'&A:!?ZM;:!<W\;3N\%O)*N^W602%,H,XP<9Y'
M6OF/QS^WIX_\,_L-_#SXS6ND>&Y/%'B+79=,N[2:VN#9)$KWR@QH)PX;%K'R
M7(Y;CD8\5^ ?PZ^&/BW_ ()\_%OQCXKLM+U+QW&=4FN-:U(JVH6]\(MUJJRM
M\Z%Y"OR@_.78'.2*YCXM?\HD_@I_V-UQ_P"C=7J')[^1M&G%.WF?:OBK]M22
M^_8:O_CCX+MM.GURSCM(KC3=05Y(+:[:[@@GB<(Z,0!*64[AD%&Z'%>X?#7X
MFQ:_\#?!WCSQ1=Z;HG]JZ!8ZM?SO(+>T@>:W21\-(QVH&<@;F)QC)-?F'^V]
MX)UC]DZ\^(WA+1+4M\+?BM'!?6<"<1:=?6]Y#/(BCHN K   922/KY==?^TU
M<:[J'PH_8L\.0-I1\/ZEH^G-+;^(VD32)[I;:R6(7AC(;RP'?@$<,_X/F:W%
M[.,DK=3])M%^)W@[Q'X;O?$6D^+-#U30+%'ENM5LM2AFM;=$4L[22JQ50H!)
M)(P 2:\Y^!O[7GP__:!\5>)M#\,ZI;_:-(N?L]NMS=1+-J2J,R3P0[MS0@X&
M_OGH.,_+/[.?PQU30?VSO$NB:U<_"ZT6^\-R6WB;P'X$LM1&GR6[(H222*:W
M-L"3(@93(,K(?E^8YT/^"9/AGPOI>H?&?6YM*TBTOM+\37%K;:B]M$DMI:X<
MM&DA&8X\+DJ"%POM5<S;1FX**;/T$KYO^*?[2'B;P/\ MA?"[X46-CI,OAWQ
M38RW-[=7$,K7<;*)R!&PD" ?NE^\C=3^'N_A3QGH'CK2$U7PUKFF^(=+=VC6
M^TJ[CNH"RG#*'C)7([C/%?&7[0G_ "DV_9]_[!%Q_P"@WE5)]B::3;N?6=]\
M:_AYILFL)>>//#-H^C2K!J:SZQ;H;&1B0J3@O^[8E6 #8/RGTKI-%\0:7XDT
MF#5=(U*TU33+A/,AO;*=9H9%_O*ZDJ1[@U^?'[-'P@\&?%;]M#]IO_A,?#>G
M^)8K'5"MO;ZG")XHS+-.'<(V5WX0 /C<N3@C)KR3X3^(/$/AO_@FK\>+#P_/
M=*-/\4FU$T;L98K.1K-)E'/"E=V[ Z2.?<3S,T]FMD^WXGZC>'_BUX&\6Z[/
MHFA^,_#^M:S;[O.T[3]4@GN(\==T:.6&.^175%:^!=/^%/[-OA'X2?L]^+[[
M6'\#:]C3Y]+UGPI#YE]JM^T2,\=QY<$S2@R9#!@-I.S*YVG[>L_'GAG4/%U[
MX5M?$6DW/BBQA%Q=Z)#?1/>V\1"$/) &WJI$D?) 'SKZBJ3[F4HI;&U13B*2
MJ,]A*0K2T4 -HIV,TV@04444 -*TE/I"M.X#:***+"$*TVGTA%%P&T8I:2J$
M-HIU(5H$-*TTBGTF*!$9%-*U(132M,0RFE:>5I*"1E-9:D(IM,1$125*1FF,
MM,FPPBFE:DI"M,1%2%:D(IM,5B,BF,M34TBF20D5;T4?\3JP_P"OB/\ ]"%0
M,M6M%'_$YL/^OB/_ -"%$MF.'Q(]8HHHKQCZH*^?_BE_R/>I_P#;+_T4E?0%
M?/\ \4O^1[U/_ME_Z*2@"II?_'C%^/\ ,U<#51TMO]!C'U_F:N5[M->Y'T/C
M:[_?3]7^9*&IP:H<T]6JS*Y*#3@:B!IP-(HE#4X-BH@U.!I%$ZM3LU #3U:I
ML5<EIP-,#4M(JY(&IP-1!J<#043*U.!J$&GJU*P[DM+FHP:<&J2B0&G!JBIP
M:D424Y6J,&G4 29I:C#4\-2*'@TM,I0U(HD!IP:HZ4-2&2@TM1@TX&D4/I0U
M-#4M QU%-S3LT +2YIM%(9Q/Q7^"7@OXX:;IFG^-M%_MJTTV\6_M(_M4\'ES
MJI4/F)U)X8\'(YZ5I_$?X:^&OBYX/OO"WB[2H]:T&^V^?:2.Z9*L&4AT(92"
M <J0:Z4-2U)7,SQ[Q'^R'\)/%_P_T#P5K7A!-4\.Z &72X;F_NGFM%8@E$N#
M+YP3@#;OQA5&,* +OP]_99^%?PI\76_B?PAX0M_#VMPV!TQ;BRN)T5[<D$J\
M>_9(Q(!+LI8D#)X%>J44^5%<TMKGA_B#]A_X&>*O%6J^(]3^'6FW&KZHDR7<
MJRSQHYE4B1Q$D@19#N)\Q5#ACN#!N:TM6_9&^$VN_"31/AC?>%//\#Z+>-?V
M&E_VC=KY,[&8E_-$HD;FXFX9B/GZ<#'KX:G5/*NP<\NYQ/Q:^#'@SXZ>%U\.
M^.=#CU[2$G6Z2!YI862500&5XV5U.&(X/()!JMXD^ ?P_P#&'PTTOX?ZYX8M
M-5\):7;P6MCI]TSN;9(8Q'%LE+>8K*@V[PVX@G).37?T460N9KJ>>?!W]GKX
M=? .QO+7P#X6M?#Z7A!N94DDFGFQG:&EE9G*C)PI; R<"L.#]D_X7:'XVU[Q
MSHO@RSMO&.JP74<]T+VYBBF:=6$H9%<HF_<<LJ9Y)'->OTH:BR*YGW/+/V9_
M@C#^S[\*;3PG$\!87=S?21VK2-!"TTK.(8VD)=DC4J@9SN;;N/)(K;\0?!'P
M5XJ^)WA_XA:IHOVKQAH$+0:;J/VJ=/(1M^1Y:N(V_P!8_+*3S["NYHHMT!MW
MN<1X)^"/@KX=^-/%7BSP]HO]G^(/%,PGUB\^U3R_:7#,P.QW*IR[?<"CFJWP
MZ_9]^'_PH\-Z[H'ACPW#9:+KMQ)<ZE97$\UW'<R2($?<)G?@J "H^7VKT"G!
MJ+(7,^YXIX$_8M^"GPT\:1^+/#G@"PL->B<RPW+33S+ Y_BBCDD9(R,\%%&.
MV*[+2/@?X)T'XN:W\3['1?(\<ZU9K87^J_:IV\Z!1" GE%S&O%O#RJ@_)UY.
M>ZHHLBN9O=A1113)&D4E/I"M K#:*** $*TE.I"M 6$HHHH$)28IU%,!E%*5
MI*>X!32*=12V$,HIQ6FTQ"%:2G44Q#::5IV,44 1D4TBI2*:10218I*D(II6
MF(8124^D*TQ$;+3*EI"M,DBQ32*D*TE,DB*TE2%::10(85JUHX_XG%C_ -=X
M_P#T(57JUHX_XG%C_P!=X_\ T(4/9CC\2/4Z***\@^H"OG_XI?\ (]ZG_P!L
MO_125] 5\_\ Q2_Y'O4_^V7_ **2@"AII_T./\?YFK8:J6GG_0X_Q_F:M!J]
MZG\$?0^+Q#_?3]7^9,&I:B!IZM6AB2*U/!J*E#5)29,&IP-1!J<#2*) :<#4
M8-.!I%7)5:GJU0AJ<#2*)Z7-1*U/#5)29(#2@U'3@U!1*&IX:H0U.!I%$P-+
M42M3P:0QX-.!I@-+4E7),TM1@TX-0,D5J?45*&I#N2YI:8&I:10_-.!IFZEI
M#) U.!J(-3@U(HEHI@-.!H&.#4M-HS0,=2YI**!CZ*;2@U(Q:7-)13&.S2TR
MG!J5@%HHHI *#2TVB@=QU% -% "@TZF4M #J*0&EH&%%%% !3<4ZB@!E%.*T
MV@04W%.HH#<;12E:2@04F,TM% #**?32M4 E%%%(0W%)3Z0K3N VD*TM%,0V
MDI^*;0(:132M24A6@1$13:E(II%,1'28IY6DH)&4QEJ0K250B*D(J1EIA&*"
M1A%6M''_ !-['_KO'_Z$*KU:T@?\3:R_Z[I_Z$*'LRH?$CT^BBBO)/I0KY_^
M*7_(]ZG_ -LO_125] 5\_P#Q2_Y'O4_^V7_HI* ,S3S_ **GX_S-60U4[$_Z
M*GX_SJR&KZ"G_#CZ(^)Q'\:?J_S)0:<#40-.!JS E5J?FH0U.!I%$M.5JC5J
M=2*N2@U\R_%;_@HA\)OA+XQO?#-VVLZ[J5C,;>\.BVD<D5O(#AD9Y)$!*G@[
M=V"".H(KZ6#5\#^%O 7Q-^%/C+QWXG^ EYX'^+W@SQ!J4D][9_;89KB!V)=H
M&D$BC($@XWG(()3GG"I*2MRG;0C"5^?_ "_$^R_A#\8_"OQR\&P^)O".H_VA
MIKR-#('0QRP2K@M'(AY5@"#Z$$$$@@UVX-?!GPA^/7AGX:_ 'XU:CX2^'G_"
MO/'?AF42ZOX?GNY;FW%Y*QACE02-P@8',:@ !0,D$&O*?#/Q9^,=GH?A3QOX
M7C^.'B[Q5<S17>K6NJ:*TWAJ^MF!++:K'NV _* ZJ,@DC9TK/VR25S;ZJVW;
M1>9^I8-.5J^./C)XR\6?%[]K+P]\&M)\6ZUX#\,1Z+_;&I7>A2_9M1N7(9@B
MRX)C &P8QU+Y!XQOM=_%3]E7X,_%35_$_B:W\?Z5I,7VCPM>:A/)-J*AF\M4
MO"8U#@%HVR').'Y (Q?/OIHC+V+LM=7T]3ZL5J=7YX:GHWQ2\+?LNV7Q_C^,
M_BJ[\7FVM]9FTBYG5M&>":5 (!:[=H(5QEAQP0 .HTOCQ\8/&GQ"\9?LMW/A
MCQ3JG@8^-H%EO8M.N7\E6E-ODM%NV3!-[[1("#W')%9^T\C58=MZ/O\ @??P
M-17EXEA9SW3AFCAC:1@O4@#)Q[\5\6_#/5/%WP;_ &Z1\+[OX@>)/&GA;6]!
M;4HX_$MW]KEAFPS95L ( 89,! %PX!!(!'-?!N;X@?M82?%/Q]-\4O$GA*/1
MM1N=.T+0](E1+"-4C++]I@92LX*L@.<$G<=W0 ]ITMJ/V/5O33\3ZV_9_P#C
MYX?_ &CO C^+/#5GJ5CIRWDED8M5BCCFWHJDG$<CC'SCOGKQ6I\7OC7X0^!/
MA)_$7C+55TRPWB*)%4O-<2$$B.-!RS8!/H ,D@<U\W_\$K?^38I_^P_=_P#H
MN&N?_:ZL=.\3?MO? #0_%D<-QX2DCE86][C[/+<L[81@>&W.ENNT]<@=Z7.^
M12ZE^SC[9PZ*_P"!VO@?_@I_\%O&7B.'2)I-=\->=(L4=]K5G&EL6)P,O'*Y
M0=/F<*!G)(YKZVCE66-71@Z,,JRG((/<5\B?MP>,/A'X@^"/Q%\':GJVB'Q3
MX;L8Y[73"46ZM+A@A@\D'!YWJ#LSA7(.,UY#\2OB)XQ\-?LQ_LJSV'B/6='N
MM0O;*WNWL[V6W:YM]JA$DV,-ZE-O#9!%3S.-T]2_9*HDXJU_^'/T<IP:OC[X
MV>.?$>D_\% /@IX=L?$&J6?A_4-,GDO-)M[V2.UN6 NL-)$&VN1M7D@_='I7
MC_QX^(GB7QU\2/B@/!OCGXI>)I?#*R!+;P2\>B:)H;1J^Y+J<R.UT08V).U"
M=C[21@*W-(F-%RMKNKGZ1@U1U[Q!IGA?1KS5]8O[;2]+LXS+<7EY*L442#JS
M,QP!7YF?%G]H+XBZM_P3H^&_C#_A+]6T[Q3/XI.GW&KZ7=R6=Q<0QI?*JR/$
M5+<1QY]2@)R>:[/]MKX :MX,_9=U_P 2:Y\4/'7B?5GNK&XN]-U+50VFF=Y4
M615MU7:L89RR(#\I5>3BI]IH[(M4-4I/=V/T%T?5[37M)L=4T^<7-A>P)<V\
MR@@21NH96 //((/-7E:OSD^+WQ"\4?LZ?L_? SP3X5\3^,-0N?'[Q3W6J+*-
M1U>VM_*M UGIZD+@DS@1("""NT,-V:ZW]EGQY\3-'_:"@\,G2OC!J7POU:PD
M+:A\4])D%UI]ZB.^?M(!7RV"!0&89:0#&0"Q[36P>Q?*Y)Z'WA6-XR\9:/\
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M^/?VV_B-\5=5NOBGXK^'?ASPOJ[Z/HFD^$;O[)AD+@2W)Q^]R%4E2>2S %0
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MT4#'4M-!I:!C@U+3*4&IL,=1111<!P:EIE*#188ZBDI:0!3@:;10 ZBD#4M
M]PIP:FT4!L/HIH-.H&%%%% !2%:6B@!E%.Q24"V$I"M+10 VBG8IM @HHHH
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MC>6-4D/H%8D]J?\ MC6.AZI^S'\0[7Q)K;>'-(DTT^9J2Q&4QN'4QKL'+;I
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MM2 4H:DHH =13<T[- PI0U)10 ^BFTN:!BT444 %(12T4 -I*?32M A****
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MK0*PVBEI* N(5J?3_P#D(6W_ %U7^8J&K&GC_B86W_75?YBD]BH[H[:BBBN
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M<_Y^M/\ ^_DG_P 12_\ "E=;_P"?K3_^_C__ !%>TT4?7*H_[)PW9_>>+?\
M"E=;_P"?K3_^_C__ !%'_"E=;_Y^M/\ ^_C_ /Q%>TT4?7*H?V3ANS^\\7'P
M7US_ )^M/_[^/_\ $4?\*7UO_GZT_P#[^/\ _$5[111]<JA_96&[/[SQ?_A2
M^M_\_6G_ /?Q_P#XBG#X,ZW_ ,_6G_\ ?Q__ (BO9J*7URJ/^RL-V?WGC?\
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M_P"^V_\ B:](HH^L3']1HGG(^'.I_P#/>U_[[;_XFG_\*\U+_GO:_P#?;?\
MQ->AT4?6)C^HT3SS_A7FH_\ />U_[[;_ .)I1\/=2_Y[6O\ WVW_ ,37H5%+
MZQ,?U*D>??\ "O\ 4?\ GM:_]]M_\32_\*_U'_GM:_\ ?3?_ !->@44?6)A]
M3I' CP%J/_/:U_[Z;_XFG?\ "!ZA_P ]K;_OIO\ XFN\HH]O,?U.D<)_P@NH
M?\]K;_OIO_B:/^$%O_\ GM;?]]-_\37=T4>WF'U.D<-_P@U__P ]K;_OIO\
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M]]'_  I1X7N_^>D/_?1_PKJ:*?M9!]7@<O\ \(O=_P#/2'_OH_X4?\(O=_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
..*** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !3!5P# 2(  A$! Q$!_\0
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M*3[3K/\ S]0_]\#_  H]GYA[=?RLZBBN7^U:S_S]0_\ ? _PH^U:S_S]0_\
M? _PH]GYA[=?RLZBBN7^U:S_ ,_4/_? _P */M6L_P#/U#_WP/\ "CV?F'MU
M_*SJ**Y?[5K/_/U#_P!\#_"C[5K/_/U#_P!\#_"CV?F'MU_*SJ**Y?[5K/\
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M*-4_Y[+_ -\#_"CV$@^N4^S.[HKA/^$HU3_GLO\ WP/\*/\ A*-4_P">R_\
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M\)5J?_/9?^^!_A1_PE6I_P#/9?\ O@?X4>PD'URGV9WM%<%_PE6I_P#/9?\
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M=_H;%]%T]F)9C;QDD\D_**O50T'_ ) >G?\ 7M'_ .@BK]>6]SZ..R*&N_\
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MH3L'':MGPS??$[XFZ.WB73_$-CX9L;@L;#3#9).'0$J#)(P++G!Y&?H.*P_
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M+5[6W\M!Y9>)&8[@-QR2>I-<+HWC:P^$/Q3\=Q^*$N+"WUBXCN[*Z6!Y(YE
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MW;0VUA8QV:01Q7+EB067!=0!QW."..M<9XZTNWTOX(^'/LWAR3PI'<:_!/\
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MN]))$SCMG:&Q[USWAV;X:7'A."%-"U'Q)X^FM]DMK<1322FZ*\L23L"!N_7
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M-LNE#5C ?[-P!M\[S,?>XW8QUYSVKZ!^'.DII'@/0+*.]CU*."SC1;J%MR2
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M)%'DU<\D>E'E#TI\P<I2\FJ]]'MMR?<5J>3535(]MFQ]Q3C+4SG'W6=9H/\
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M_P! JY_[\/\ X5Z[16GMI&/U2F>1?9]9_P"@5<_]^'_PH^SZS_T"KG_OP_\
MA7KM%'MI!]4IGD7V?6?^@5<_]^'_ ,*7[/K/_0*N?^_#_P"%>N44>VD'U2F>
M1_9]9_Z!5S_WX?\ PH^SZS_T"KG_ +\/_A7KE%'MI!]4IGD?V?6?^@5<_P#?
MA_\ "C[/K/\ T"KG_OP_^%>N44>VD'U2F>1_9]9_Z!5S_P!^'_PH^SZS_P!
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MVT@^J4SR/R=:_P"@7<_]^'_PH\G6O^@7<_\ ?A_\*]<HH]M(/JE,\C\G6O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140392662238128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 04, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  04,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet,
Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los
  Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>radnet_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20230804.xsd" xlink:type="simple"/>
    <context id="From2023-08-04to2023-08-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2023-08-04</startDate>
            <endDate>2023-08-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-08-04to2023-08-04">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-08-04to2023-08-04">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-08-04to2023-08-04">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-08-04to2023-08-04">2023-08-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-08-04to2023-08-04">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-08-04to2023-08-04">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-08-04to2023-08-04">001-33307</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-08-04to2023-08-04">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-08-04to2023-08-04">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-08-04to2023-08-04">Los   Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-08-04to2023-08-04">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-08-04to2023-08-04">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-08-04to2023-08-04">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-08-04to2023-08-04">478-7808</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-08-04to2023-08-04">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-08-04to2023-08-04">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-08-04to2023-08-04">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-08-04to2023-08-04">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-08-04to2023-08-04">Common     Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-08-04to2023-08-04">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-08-04to2023-08-04">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-08-04to2023-08-04">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MX/N54O9]X':JY0\-HW\!4$L#!!0    ( + ^"5>?H!OPL0(  .(,   -
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M 5!+ 0(4 Q0    ( + ^"5<'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ L#X)5UWH+6#O    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ L#X)5YE<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " "P/@E7FZ,R1D8$  !T$   &
M        @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ L#X)5Y^@&_"Q @  X@P   T              ( !B@P  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " "P/@E7EXJ[',     3 @  "P
M@ %F#P  7W)E;',O+G)E;'-02P$"% ,4    " "P/@E7JL0B%C,!   B @
M#P              @ %/$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
ML#X)5R0>FZ*M    ^ $  !H              ( !KQ$  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ L#X)5V60>9(9 0  SP,  !,
M             ( !E!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D
,"0 ^ @  WA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="radnet_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://radnet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="radnet_8k.htm">radnet_8k.htm</File>
    <File>radnet_ex1001.htm</File>
    <File>radnet_ex9901.htm</File>
    <File>radnet_ex9902.htm</File>
    <File>rdnt-20230804.xsd</File>
    <File>rdnt-20230804_lab.xml</File>
    <File>rdnt-20230804_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "radnet_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "radnet_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20230804_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20230804_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20230804.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "RDNT",
   "nsuri": "http://radnet.com/20230804",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_8k.htm",
      "contextRef": "From2023-08-04to2023-08-04",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://radnet.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_8k.htm",
      "contextRef": "From2023-08-04to2023-08-04",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001683168-23-005434-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-23-005434-xbrl.zip
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MIU/ G9E)WC*&6*;>\ >^"\);RA(<=[,N]/EY>[W>GS]2 Q_F"JH;9\]<&91
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M=YKQW<?B;EN$TX.0&] 36]!PO:;'AM3HAZLU/-\-&N#BBF_B0CX?C_K>T'+
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M_&5,]=M/)]/OE9'T3:VPBQ/CQQ?E<N!>[+8*+:>B?[VY&80,_']02P,$%
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MW'<^;F9?/^_A,]^3<QYN(>=,%*8^]P$2(4Y5LAI-=VJA"U3SX"*;1HU-B2P
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MA50($ONPX1Y7SW8F,C)1*L)>BC;!7B54(]@)T@<MPD>E5@U&%_= =UPU+K:
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MZ8??B4L?,(_.;LBB:7?X1X=*0?9\QS-?:!-VS%:I-#W%)L4N79J)XXT[R')
M"A)DIS-E2SS[Z=FSJBYKPCFA'6UU]O3AV;.VWLUVCG>)W4V!K(7!/^=/%J8I
M-!XG1LNKR[J\1+XUM:IC(0$7!X,$#3E3UP(H&T"D2$M]]"B^<%%;Q+D!HS1M
M5^@G\-F](*#MHJ!$*4:C<=J5+B6.LD"*;*I,V=D$\"M*5ENW# G9%\UJA[UV
M%:H)&) ;)ZH5?6>7"($P+T!>P&5A! 2U]#.E.-(UQC2*EI'[3HV*"*8?WP)"
M)_$)@IE?0+$RMP!0+;JR97*M%QDLEA,X;"1L=X<#A@PK;Q8 N>.&X)*C"25D
MS,BA:!XX15T:QL%$QH!#D,J8S5)/S!3%'&8F()G ;[KA:")\HR(0BT.=DJXQ
M*1701)&J.;C7&S<+O7)^N_*MOD)W8<";@%D.?H!9O@.8Y> 'F&5+;LEM1.&V
MR,(U#8JXJHA#!$!7,S5CW1?T'S3XNXE#3,,WD;%F$Q YD2&(,)=/2S*>*;=/
MH;M(27H?25B7E):I N'>8(R#WM0JNQH.!) J/MO[D71[P);8R\CZ%9D/ DK2
M0G.09)G"E5LOM5OYI$K@ ,JVP8QW6?BPU6QVR,F)ATB24Z/<ZI;/<JQ(NVGG
MI+DZ#XN*?2Q@UR%Z(8'7P/N5J-:@J0)!-*3?DKN!<T,1[>\2&_L)HG?[%)UK
MM]C:F_M%XYWA57C">1:IB\&N3Q1"I['%HRS4"C-+5<L^1%C=:#AP.7+JLC:%
M,VZ*NAMC:NMZH)J +XA*KZ]@'DS*E"0+M-R"Q4.)LI&+*Z>X#*)SUD(_F#M#
MPR-:#/17471]OLS:N[=8Q[H-#>HMH<'K*!&,XZX"A@X3"J&XAA3R*&8GX0)M
MB!1WS"XZ8IUH*/14X5'VR%CX3,^2YFC><$!4-88=5.Q?CI(RT9 W^(HJ.Q:I
M$ZCCA(VJ37@/9[7P;&"4:Y^V8-F8"OWY%>8_%>::2QAYZ#&?JEVQ!1G"D(:\
MOA-MED3)_2 -+@I+$J#EY7?<V9_\'4QAPO2/!%L03T0LT4='_&YAU))NQVY7
M'6$YU7)9@BZ,8H%Q,RC%^8V1X"]T,[%FS%8<B)=)ZXTV2BGPDVWK^+*S3_N+
M^[O+=1/X?8U_&8DST^I%PQ0$$Z-S=O(5Y*6:6;6<PXF2%]TZ< [J)H3;0#P%
M"\Q76.:&<:!)=0CD)='?8NY$EBE,J%LL'&XPRH>A73[<"^4$:+O)SB8@$&I*
MQGI/?HHL/"3?0D;$M!*JN?O.(,?#IEO%P_XU3I8*UUBV1E23KR4:K@E3P5K#
MW>7 '5- \U=4E(G7\?V^XYI4[%0GI'3?JRX5QJYA!*+;HB>V(0"MUT@;[1)'
ME0086_515WTN+/#7&-X['"1)LTF<W&G'L1)NL1J28\SDZ,-Y.XZ(.@BJQ#_\
M_M_ZGAZ+_H?4$9V/U<O:DK^S:2T8K&!-Y1EE7L#D,-HL7E0X1(H]^X!T_P03
MC<3 [>\<JT:2;5K5=EC_9>(T6]4!K5C#48829&4I">I+--18K[[[+'R[_?F(
M!N B7@M))@U1=U85?56@/"*$Y)#(Q>YQN$D1'3*Y43UJU^OH^'&' QF8\V9Z
M(R.K(M)9<^/?<?MD:[U;QPZ>0"31DP>)BP.]*F.%X5YTUZP'7N"!*U0;8R&/
MBB=_")^MI 0=8@W;.!XQ'.R(KX7XRL%1!AL""JTJ3"=2!Q$[-><8[T8F2]M3
M#/L9X?ZA?J6'5+!^6\9SIZ$4!S< 4IC+&R ID-"HXDZ]IG:D(FJM@L_H6R(H
M'H_^M@GH=J?/;/\F".^#FV&\3\GM3+?P7L.] TAW*_ASCTO_ONS9UO4&GU\/
M[MWW:Z9>#JI6!;\1(TZ*<''5R)!)5U\AAXZ5!13=745 N79NZVXV=Z41T65_
M&7'9:,91&IZS&R@WE_^Z=ND34" 9%EAOL5R!_E!/.EPJ9A%M2ES]IFEZ_Q<&
MO$E$^_!'1/L[1+0/?T2TM^26W(.4AS/@L85#J6^*(9$\P;IVH7(O2Q:)S#;9
MT6@_VREV21_7NW%].M05<E=@S'+L?(R5[5W8B]Q;(4&35']!WN_L'^QFA+AW
M_B3QT2>AK[2R; !HPX$T4N=5:LQ:?5E_Y!JS\"W=L@";Z4I;K*!G-;H425Z1
M3UZ\&PS/EV(4D2>_7UPNU!O"$@CTL'>,T M-7(5J#22;A/,=-):J)L52.>=:
M%C@N&U841S#3%K84QD5G.$/4KI'#%!Z@96+@L>P6RZSI%EF#E29H>O R/FX4
MO,-!J#PE=0773P:&71?:4@;P@QMW.'BG5KZ,\]DTH@;& D84D?4(@L-9F/:/
MU?9D!N'E/8*@M5Y75)$C"GY6P%')Z$CA<;Q84S58GH\4B0PK1/&+HK='N^ "
M5B%"M6E6?C7#P=18@@'X=[@"W4XMNLW!1J?J2_F5JC<^)_?A\&(!-QJQ*G#$
MOJ3@ZKKMW%RX&F7 # LYLP.8G#A1Y<UDE_-LY],NCXT^PAGYF<K2D5LS' 1]
MU31Q#3-7%/SQ:/^00XX<P5KMRA;A1E+X*5DMN['2D_:8D*2J&I7_DC4!?6",
MP9VF0VYN4F.Q2F3@CK'Z2T.X^/KZ0=/L_[F;G)KLAK =GQ\S'%"E18(+497%
M-'C&C4* <&**@"\(<H"FVSB>6M6(FM;,-8Z.HC#;=4L<9;])"9KAH/K\^<N1
M@]#C%:(#T3(CX*(]NYPAM<YGB&E?U5U9^)P;XKJ>-?'?X.XCTQL.'#D\VOOE
M6/AF7,;=U==L6JV2$9/KO 03H5.5)]7X>-S$2*PT+@>+&';#[]YBJ^(6"<W;
M6)D2N/Z4D<Z*DIN.B3S[[H;L;('8 2 '8-:45Q9K+%Q*Q@6+8S'+S5KHZM?5
M Z)<5U.F36K#2PL-2N!R)"5:1N(KGT33!1HBN(4W65N+Z7- ,E:W_8@9JPAM
MJ/ODY&6\ </!61@RB,Y>[QH8.4?B1Y8J[E:L6MTOP1,@'[@"Q$"5=?.9%43+
M1 G!2/$(<4&;<]W32<E%G,>D;\_[LINAH\Z&(&=@='0BDE,GRF4OOKR&]G>P
M?$ILKS07#OZBF+Z!.V6'B$4*)H>ZRN]HZ/6BSN1A ?:9"[RSI, 77$;Y+0]Y
M?12KQ;\ I758;U5[K<]U?L@925&BMI)+BX4:&325+\*:Y8CD001DA3^ Z83?
M ^49-(LE#EEJET.C"N!O->-^).6"*<AWM;F"[6YJ+D+&<!:>J$O)Y*4XT4</
M#P?\Q[O>RFC+W8".&[D^%)LD<-HC0X([=&TZUCAB9I.=Q==7\EGY*'/4819Y
MVE_,U\;R'(R\&4!H,/;5''D+_$P-AJ(^(9@1IAF%!/H)J8'6M4^!7X"GSZH:
MCF.2P:,S_(B=)$WF>@PXH4SX2?]UL"'E^V%#*"[$^T0)W05FT<)M59R<O_#]
M4#*_EI@!QAT^,/Y4E_5L%>KZ2^0I>448$JZC>US0>,IR@IT?BDK[2FGW1CL8
M,O*J,98>;&2Y&T 4]Q,SO"V^$7_%&JIZV!)[5+#_BR6IBV"BU1U5"\80M?L.
M!Z\<X\;O<=7K7GE%[B+6AT+9J.],S(A]EI>7;9$\XIQWH AJ!>3:!6[2,23.
M2L%:6Y.)AG:"DRU$RI2][B76O YN&OF4X8D;\)%PB[7#9RY102AZI9G;1'N[
M#Z0ZV1)2[1$L:+TEC'PM6V?%;Y,*@C]V$]VC=/F0! &+&](L5J2$4/LX3=7&
M$?@*/Q7(7,VX8W4$[@4&9'2V+B@<Y?9U8H2\DC%<L$V):3,=UF$%K<4_O*;F
M!>7E2O4;.#G\*,R,=/W^#/#N^*OC1>:&M67QXK*;K,VY8>X'DW9],Z?"MUCI
M)45@78$/<&*# JUTE7P1\QV7CT6 85=I)% X=_JP<;(N3YT<"5NCGIF^)FXR
M&82+DIM6TEOAQ0OU4:,5%[W'NZ/CA[V?$!'JN!9,[LKH&2X*S%E7JO&CWX\S
MC:R\R<>JOBIU,7/&;V^+N.F)(I_WAL.N,JK+*K<:.+[DA:<RT%V5G#! UY5R
MIC S<)V6G(#) *6>F=:@9_VZ#G0T=R05=AK%OH P778K23(,GC@(2?PK3L54
M?W;2&7/-L4^#NV0\$'N@=\)V(>%)3GO3^<: !.(7RS?1!;P*@"[8>@'Z+ECC
M#DXG1!R5G<;0!*L*TPP#<*%-C'?!A7.ZU*%_+;D+VK24IQN <O3GU'6/@AC\
M<>Q>=%! IW,'(++?QDV=O'HUO)FGPS5T995<0PKG^F4>>H6&@^O,E0 24[P#
MV>!X+FN>':P)H/5'RHQ:H*5BA54I(Z8&&KY<G_I/@K->D@,64_CB[X4Z!L[]
MBZYY2>23/>'=RMDU@A:"GO@002!5$*:UK32BTZ<:[RJ7*R)VXBICIV7"H]-9
M.QMRPL_)*.I?0["Z/6$GB8^M[7R;3>I^[GP>GA!QC>0.=<?#$DW2<YJTZXH)
M./Y-$P4=D?<EU%_/-V \<F$LM&44<\#[Y"]3OKYO7',"ZQQ1(:N$)ZUS(MJ!
MX8#IN;</R/V6NG*]><."(W?O!D^4$QA)V@^UF$2//6?XBE6M/+(M8JTS-.D2
M3A;</J U8V4M)(*Z_V:O8N#UN#83$(OI(OK%^0!8U(4"6_&(6RRU[L* -X'$
M//H!B?D.D)A'/R Q6W)+;F=1!"XI,;XFKCQ[4_4S3[]]Z6.XKO-$TS7$]POV
M9(M3/K,=*_OJDIL$A]EXZ>_"N4X3\!VR100$+;,#M:<,SUQA<#($BZB_%OXQ
M/+#6R Q#),U4W8<PHYPP 5:C"![H3&O0#+ 4^GN1:(K7>C1<X<?UA]GU]5P,
MA!_E$?^%&N"/;X8/?\4PJNR=5Z2^(39\_PA;0$:X_9M0Y.-?1H??M1WDXZVL
M(G[L$\$VMF1"+LFY8JB,NNXOCD=36!CE)KF1X\("'"SMJ;/.&/#!C>'@\]&-
MT!E2/).DQOO,M7B\./F'A_*F$%;=P(J&:LP)_/4(:QG&/6_8=R3K[$U:HF'2
MC-4WDX]=D&0G=W8R!UO7.C1/6A,.VT.6O@TQO&D=%G#'.;[0^#9VI3B%([ Z
ML8*HYU%RSJ)>-&)$T1.A5'$<8L'XNB\QV(.].>C: @G69ER*@AT%38<155V(
MBN,=(13E\V]J-KXJ%G4<V4W>XST]$P<G0^,4Y&8)ZI ;D-U9C K;C(XA<EZR
M!SNV01LPWDM%33/!E$X+NVX:BV^>Y/S>#[+>1KS4F[J@"I'$<;G]>8^FQ9G(
M*> %ET[%9\C9@)7(J!)U.&LL*&G9382LD &'H&?,/2$B0;?U_3C3;6R8^,&)
M&784LG1N0I.V#;C$_KTSE=1&(X\B0ZT8)T;0JVQL&,2)V+G$@\MLBG!9Z2R6
MJ,"W0?@V::GV7HH6J@C]>NVP<W-ML#<<*Q#X@8^JL9,OC R,RJJJP4 >G,%X
MY3 B[( MU57PG@%%DX;BHG>,69&-P,)Z#B&KB()7O"UKC(^^*37LPQV@,,2?
MM:G\SM5=Y0'_S/RD'B[G3S3"[^_']=C&UH6OJ'\]4N]K=;51C)O0$)"#.0AH
M*+5$BJDX(/S[NH9G@"=B#^P7"!T&5?,%; H\5QG%N>J(T/DT*<&(!.*XU%6G
M75Y&:;3WA%/W;,W.[N .)M&'L/K5&D_VT4?1FZ>)H ] 0Z^^SFC-KF] $3S:
M&YMH,OK_R@_\H15H=UA>Y* G#81U"'I"QI:*BY?P2$&%[OH]%B,GLX1!G"X^
M,U3U6P*F%,<C]&&IW0M8*>&;W'PQMP!_?>>U(.$IK*VDH6#/Q! 9&HIR4G"P
MH4T@]PW,6JP*Z0<>91@<;."ISH-D&."F6_$AR0X4:VCRE[K@A*)C.S:M\*WC
M":A,OV2_CSZ,7HS\*_=S-$LT,&[]CU%.1@G%086C$15A'(NGO]T-QV_!6!Y_
M=\:22%Q*2N#*,ZQ$G?4BGQNHPF$;J#<*0L):)N[%4A,"\\_.FJ80; $#($Q%
MUREG<[2/?LA9.V< @F]ZQX)>+'&<)WR'D(*N!/NU4(7[02D_?W=*6:>7E]S)
M&56SCI)98NW,6X9EZ9)V)!%(G@HFE* 5$*"2?,-5YE)-Y@$M+N]P.(B:+M=@
M[5F,H(H'!#G4'8OYW8(4_O;=22$F@G,J,R<G?URMI.Y<$T!A*&RZREEGH?D/
M%\T1=7J#M(],,'(:N,\+/,S"93(&0"9\8):$-Z& 0V@MD,#T*;,76$N)K<6G
MKN'"A@2P0E.-)@=<_KVBKNFD1#0T &@YZ%]F&](B-F6&07&+ \.C+<:FE@BF
M,2PG55%8[&Q5Y&Y,YZ-(_'Q S>]5@5W#WW@<=8Y]/4=YMG^TOP??Q)R&[/A2
MPR>1^@9ZVW'VR][>P=&#X>#P<.^0  3HOZF!I-XH^Q%F7Y>P&T\$_9%,(F36
MBOB6^<+&8PX=:GD)%F7.J<4,;\)HW_:K_'=AP)L$UH]^!-:_0V#]Z$=@?4MN
MR2V$Y2_?75AN$IG9WQ7*IJ N1>V#I,:U=]*(:OQ%13Q$J?I8+[#BZ754O)2L
M1#\.EE$@Y-6EST&6%R,S9Z%(  ">!5NE\0#7@,?NJ^ZUO_==Z"FFGM?D5'RI
MI6+DJ0 H)2.X#W.%HRE,L^Q0:=D4B<PY]XH/W:M8O@QER>X=2:3'6L/X\JE[
MN4=O^N9+"TH^F'3D8X)AI/49Z?4RD=PE>45X5T%EBFLGE! '2Y\1NNN6Y7 0
MFY;WA+R^3UP\33WOR+\#!/'92(HOQ$ -[,(S0E#4:Q1IHJ^VLPL 4\]!&II*
M45)+*R'AX4#Z2-0S]FK[^)D#>6(&L_,;-B"@(S/RGI# ]PP;)W"(X+0+QEWD
MSLW=?28W+_E[7?(^_N**XH?<:1_.#9:&Z[=>806<JF!W9&CK*XYEH"5D0#Y1
M+V2!8U,A*FMJ!1Q->=Y-MH-J*.?W@='G2@HP2D%<J#Y!W<V!Z(UGH3]-]))R
M7,CM79"1B157\H1%8A(OQP4ECJ3"EN69SQL!/9$;W,22G6S 31[KTY#:>"+[
M^QY?U7%FSSMTLA<$H1/#\7@!AX]]E1(O:]/4$Z-\_QV^3!*\KNU,5>:?*H2W
MXW[%XKEAA+D48B&$NJOPA##[R/]'#G0MM]AJKLN$&'<:-7=#H!BYHAP1JC[A
M/ .^'$+RQ9#<P9[?29OM@*RQTHG08!$I7>RBJ[ &L<!/)B-@90=K0CD#/%JK
MFH;FO!/!\G':_2E+45\08 I]Y(W^1/_IJ*>UX4@>SAB3)F:,Y>/W\!?@WE/%
M 4RNM@:[/TKU;]\[.NJ&S7-UC14%XA_6D:3N<+-1<JKG[ K/P^ER<(2SKBDR
M2"_%KU@]Z\I "Q86CC3GZ7SJ+K"<4FT_:DOPH;CH);EIHS)HE3C]? V+#7D9
M&TKVAS(B)/%[6293V :\2!FW)N+L]N0DPT6AZE31=7F[Q%H[7845&UZ$3!7.
ML&.G\@FF-K4.M/I2&1L/@%O_6XU0R9E+M0@Y^>(MX4H3KH2(%#>ZZY*'\8TD
MYZ,D)U\N#O4Q,D4HGH><7*B%[PE5GE$^OKXL79-YCR-"9$7$G#S).@%B/8/C
M(&)!1?A=3\_A@%Q42=F#QM>5HM=)D3B<YR@3MW3N^&W<2#WQM%%]I2^$+'+2
M=S"?BF+@]*4R6<UFK3HQW)+OJROJ(T$U_+C& =I?)5&X7<4Y69(;RGN%7M,6
M=6*JSX>Y6E2OC6@^JM3'ZA7FMP?UK#>!7H4,K ##K#T*^[ZH"PZ5FDM#4%8^
ME!"O._C;/CJB[P?=(RX(-@S+_,4'%2IEU$X3G5'%@& Q*9 ;+-PKA9,KK$)?
M*77.Q?I:JN*V#A'C=*\ [85E;/@@IN/A(#H.#Y^\9)/(YP*'KYQB8CJR8SHZ
M.>,0DN=715UZXY6ZXFH]C_M"%4!MKA3E/.GM),*%@M<^H:V19(-T72&IF$(\
M<&$G^LO(@U$21I)4MGY*I?28C+)G45I0.MT7<^_D8:JWHJ,V#Z*PT>=26%FP
M/[9>(NR%\# 4!+?U#(_-:TMK)SEWM2]"LP]*DB35,<S5F^@Q'F%=,?&U-JDV
MXAQ[_P3+J-FX"]?,B\(2=NW H]I>,1(#$^LFQ@E39F!Y;-[A=I 62)V\4"Q/
M62-N/*6Z7EPD+*1=1AC6B"P99:=>]18[D]2<(O(5J'%-74(CX&A$:<-!H/DF
MR0'%PQ9^>%NU.]N@=1\??S7NMW\XVA<0_]]&!S<$\>_O'=%WOR?GY,,"KAG[
M<GQ\#R0*Z:$45',G[6#??8J,T'B"['%XH[I*S9+_ZHH9G1.1$@U&$M520:\H
M'AB]P_DL*#V^<(4R6/3#'164 3"O1/;SY2%GERN@MFG>%. ;KSQX/3OU\L'!
MI,98<\UP;@ J"A10<TXT3H;V:>[D3ZDJ$;2>0&-N&NGMDA$0IPFSFH9C^K8T
M<$2X1\Q%' !0MNDX+"D&\*C XFVPPGA$X1.\+7'^,H?O96$/_3Q<"AE8],$"
MWF+EX2X,>),XX>,?<<+O$"=\_"-.N"6WY)9&0&#N?\4.P=>H;!Q+8?WXHPB?
M:[*\X)=8>W//.C_HSOYN!!WO%;UTFE,HQ^JX_12=),I-8N?@2X-0X!"K8'.D
MCY/+KJ@L)D@GJUVQS%!:4WRJ4?W,A5Z,J?ZQ$L>BCHMRDC)<Y:Y68%0F*Q3I
MI.G/UA/;UI>%?J3-%K/3(M H<=HUAT6UTQ9">2(LT]$TG=1UX^%0-XY*VH?@
MF'33K%;HBL:Z;T9<'V37%3%D/A'%HRB+]S,%FLAB1"5D:L(,XF(8+!<I$X5M
M+6/C8Y1*I,;5 '%E=J+A2 M3:%W!:9CIU$E@TINPYFG+Y(%?;QHY4+<+F!$N
M52BG'0%Z^%M>BCMONJOJL3;W4:],[C4;(:5"&JH!XP;-N:=>G"7AW1GTD,4H
M9"=XX*@D^I?<,$']"NYZ#E=9J66"0X.>LR*46$!=@ZU(N1(];95TPIN<MW+O
M8 !S\"O4UH40?-^$4/;6E5%IV" 70X8J-<MYI&=!-9NW6(VZM25!G=E]&XM-
MY6?67 ICMJ_A<-F?+6R O!P8770MD9VN[.Y[/Q:U5JAN.'B.V5YQ)GVP$[5F
M>B.H?A^"#WHU^9#[3C<G0W"X%^) W32+E#%R%*PL$U)S:0"MZR$HN0;=D@O3
MH?[@\P%6Q"[8%8%Z_9]@0)%6S\6]J"^')'#.D-$2E\/"M3S)NTY@$E;]/FF+
M<4#U0GT2F8TU^R6F&M?_0G_;6L/)NE=!>ZQC#MBJ3W1V*,,E2L$- )JT,4M2
MP"VU\Q*PA;0W=?&B7GJ;OW)XW<K5&DR$)HRKI*N(S@#Y#7BK*I%B23@\=)5>
M,2YJ%LM:HFV)&N-*TJT#G5 1Z+3+1G<6I:NA9D--=<])>GN*T2"ZA.YN.]7C
MKI.ZJ+(UZXT+]<DLNH5S]'NL=;Y!327$O/@'ULIJ<:B\JBN,N#'>&2MMD;<B
MB1%B+$9:;@>O,4Q$JTI:G9R1I@@,Y[VF/#+V5L>]+$+'G/"9PQ*@2U0T%D8X
M;4I)DBA-R95YD[%'V$H@ DBM$Q95='.!+/3K;-3KXV)DZ\25;:2MM), -HF-
M\3 ;^KQP8X^XQT)#%+Y6*T<5DJGN'#"8659;ZBX#RFM5B N[2>:)K\?KB,7O
MZ?9C JE+J:#8&*6_UN)-AKVE+B9X!,Z;CB">M)U"#0_LYI\[ A:6E/A#X=2%
M\[R#G)LRNTA[:CEF>0\NYDMVL2&_:WBY??7F,XUUI(>]7,:&:G32U\BY)I:7
M7#Z%U#5U!:*2C73.21F4(CR).+@1RE00IH8<KM3.AJ83NMFXY#TTIZ3AC37L
M/?>L>AIM!V&_THE>K!7ROPD'<MUTDNXDO:8Z-"G+78#2/A= ?QQBQ289N(G.
M*$BZJ[BV:5R7WU((MU^1'+=E(A&E=AZ75?;K)^;E"FD13YD(;I(S5UNJ[\DS
MXJX=:>0V=K3?O\MR-NVWM'&]1CY/^U&X,I([US!5T\CAN&NUU!,F+^?<D%%W
MPI4B3$L\'K5T>G]^YKHPL6Z4GE6:K'9;WIAM9HW#@6_^Y-DZMIF"N>QZ*W,:
MM",<YJ:R7-9]C5SR!6I14T- @E/57/XS8A/,IVSGL>^.%UK-T"VXR5&&,G)
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MQ W(_.'SMR=_$#?_[>+-ZV?_ U!+ P04    " "P/@E7ZW5% 1!-   NH0,
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M/=)A(1M^F(93(-_L1PWTYL_,N6<.)=<  4-'H"$P+X<&&X!AQ_H^XNSTI#,
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ML!'\D=W4&Z#*Z89MVO=/\!O' @A"=WKP0(,.;5<8&JP76"<3ULO,E!-[":
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MCAJ%2:=*]YG^>^]L9UX+/BS2.!6)"(?[EXMX^"'<I=P_"QS"^ ? .MVBL '
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M-*!*-5JI).XO; Z!HU\06V 6WPAF16 VS#/GUQAXR4'-<33KGF%?J=>61Z8
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M-QHJE[8XR&G<$[!<Y:BTM$<&-9/4$6KU3^G%QKE<I>6-SG:*2>Q<@7,C'4L
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M[/++>0 H!@XRAA65_ZS5S:PD?09YW=%UZHY2>=/K/#D$ PA6D@G$.037:3M
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MF&M^;O4:]=,34.  YA9PZQBK%W>5J>#V%%X&H8#B$74U5 ?B"AV%]_M#(1)
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M6-/^8TW*06-->XL&+8#("SY !U9/CC++N\^=QI\\BO:M]_WJT_\'4$L#!!0
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MI'Q_M41=#&6C*E?+GT\< U$:-$2E7=[,5L;[ZFT(<?%(S<*/=W=#,)JD8/L
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MHK.S_2C6.P>Q\C;72([<"[DM/95%O$_NE3L1,!4\A;^3;B%1^1.QJCL^/,A
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M(5U&,&=MD3&C#]EOUA,:(:"DC,$&'_(#%H!%9&R;@[,_=Z@^IK'KX_2R.,!
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MLA,2&DR(A<IEU6KWU2IK6-@J6*",&&57[N0$#B.C$K>.!I1>H/+57;0P>"Q
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M%XEJ<(U'()(*VJGEL@P4.7ZH7#M/:K/(9ZP^]G%UZ_IM?TVZ*J&3A]][7[W
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MT %$B3)E;U43U^JZM#GM7/NA3]%FE?M WRZ4:&WDG(HM4VF19I+.ROH.MLV
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M:MO_38/:@_'\(EF<?]+S_USD?P8]>0X8Q9QV#0BD&];7N(4<Q(X@4+L@$/1
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M;0]G@THOR+2M6H$YR,+#I>6M#Q85H-8S*L0G)OG"ZE;<"?Z2L A>,D-R+\
MIJW4&-KPT+$;[..G6A#K.*]C3;$H[_V2:)F?4:9ITC[$%)KP(&D:ZQU<"K5/
M).YXFF'Z[^2Y\T3<+O:"A]6P%9*&,CQ4;/;Z@"EBD SR<6)=XJIN:%A?)3/*
MW;T";+%U> 6X5A@$!#9'[5> BZLGA<AU-RM&!<' B- L=M;)%E-5']?*PNCB
MMJ%6#^??:ZGQ\456V5WHW2-G\ ,";8FKGH;,Z=XVRX/H<<"4V>NY#.4Z3U?C
M58:)U#Y\U\J<S>RFG6HBUP5!]*[IIC5-ZW+'O?FK2#*YYQG?;+:LO,MC>VX0
MT+GJY4Z;NL>MHB!ZO\N924*I14VQ8RP6G"91DB5L_8L\^10)MK7*)G(%!&Q0
MT]!6!($":,ODX"!$6ND8@CM!%(1$=D3^$J!*+"1N'QZLLWV7V!44_88U'+ R
M"$AZ[9FPR(!Q5(M 10C*8_QB,T_3+1%O@L<2X@DAT#P 4DL?(DZ0R5ZHBD"?
M;"U(M)7SXWYZO%HF&;6=7+8ESN8DP%PU(QGE0; !F#)9R,L0?T#3X[^L_HIT
ME./NO^%+@57RV,5^L^(4R#YE5;F"H,.BYL B"0(%V)=)PPU'I1056A_9J1IF
M+<TQRET!8+6EN[Y1&$2GVQRUOOR-OO8TY%_NHD=IB@ O)-AEKH=^FTES^*]K
M@D"@PUCKI*24(JWU\4+"8<I:]R\"UMX6 >N>1< ZQ$7 >N@B8.UM$:!W6Z0(
MD>/2[8HF:PPD)^Q4NX:BP[+)AT4:%"JP/W#,J$+0(<9U1LL\Q9E*SR\V^?ZO
MY =+*P&=LYR673:KI)8V41",=#EKI;4LDL[5Q$BI77.QC9.,Q(69JX1A%B68
M5ND1;5?$^T.<T3+0? 5.CSX,AH:9;.%4A.E<AE7@(=6EZTOIQ0,8OQ)*?V;\
ME2T(3CDC<7$MQ7:GJ%OO]HF9'MO-AV8 <1 X#7$(/#JC@L9/*@KIL/)*F!>2
MOG&Z91D6^;ODPC8R 3JWY  VF\08HH!(L3L#"*G$J%#[>4&[R!Y1+;**WQT"
M&PC)';^NW6G:>&O;J@V(F4Z#T#O<9<Z/P]JXB/+TBF5&U.]%)"_D"\YPZ0UL
M+R1W_5)EEVGS;4J;-B"$.@V"[T]6,2I5#-9,>4L9(V9RJ;7F'4^)&RKWB6-:
M%MNY8RI)0'C8?'5DD!%(:[VPL-A@2C]OTX21%)Z(#)5;%JP6FRPT) &Q8/,%
ML)!+D=9Z8>%R0\1:3F\_"?Z:/9;Y6<&V 6JW;'1:;C)BE0;$2I<_@!D=@HH8
MG5+7#SR[0T+Q(LLBW%*+U#$VH%F#F98N)& @<RU:*(G4]98;GJ$E1U]3@K)'
M@B[+GZ&K9X(OZO'U2R-1I%Z(*%;E+,;"AE"7V/FOCH"&6[\]TE(& 5*O/?AW
M2*H(I$,<4W,K&1;U\[C<Q#PC&_!MA_X05P0--:\YZM,'0=- DR93>5CSY#H/
M1"K29S:C>G)[>(G7$#E>&5L,&@OCFB((1D!;T+*X_EL!?G+G;5<TB:XHQ_!5
MEH;&<<:\MCTC6=Y!$! !;5=0BKQ<B'*EE_[_C-F3V#YGT?Y.\(@0]9156HU6
M?=??!D:[9>9-36K2-"@T(,[>XA<@\% %JM7QH39C^;R8IQX:5]G<>/2T>,3R
M -YNLU3-H-(8?!6\,\CQ[84!#3!N,G1$!(3> )O0#8<\$N6A'U 1C&K1GL[/
MTD,60!)_WM^3!R+4>P=+LLL^RQT]=9QA#(AU??8VN#GFR5QO8! 0OM4M=*J7
MHGH%:*6>$2NK0+^I2E!>B^WWR^N;KN4GN5EODG^M<$KDEO\"4$L#!!0    (
M + ^"5<@JTJW5 <  -%7   5    <F1N="TR,#(S,#@P-%]P<F4N>&ULS9Q=
M4]LX%(;O=V;_@S=[G81 NULH; =2TLF4 DMHN[LW'<56$@VRE)%DDOS[E>PX
MS8<E'VY\X *"\^KC?8XM^]B2SS\L4QX]4Z69%!>M7N>H%5$1RX2)Z47KZZA]
M.>H/AZU(&R(2PJ6@%RTA6Q_^^O67R/Z<_]9N1P-&>7(6?91Q>R@F\GUT2U)Z
M%GVB@BIBI'H??2,\<UOD@'&JHKY,YYP::K\H&CZ+WG9Z[TC4;@/J_49%(M77
MA^&FWIDQ<WW6[2X6BXZ0SV0AU9/NQ#*%53@RQ&1Z4]O1\FC]4Q0_YTP\G;E?
M8Z)I9'D)?;;4[*+EVETWNSCI2#7M'A\=];K_?+D9Q3.:DC83CEM,6V4I5TM5
MN=[IZ6DW_[:4'BB78\7+-DZZ97<V-=MO64"_U1/-SG3>O1L9$Y.'O;:9R*MP
M_[5+6=MM:O>.VR>]SE(GK1)^3E!)3A_H)')_;?0VK2J2"&I<N+KNJVY?VMW1
M]C,O-%-T<M%2B3"V[N.3HW=';US-O^^(S&IN=TO-W%[5BKH[K<X5U528W.B-
MW;!3A"Z-W9EH4E;DVH?URS#CI.L=I1>UW5Z5I;8E^[%0KKM1=H3+>*=M[NC+
M/:/EGIPSUC3N3.5S-Z&LZ\R[#SF%G(#]YT?>T.58&T5B4];$R9CRO/X?5K,G
MZ3;0JY+$HZVQNE.[BOT^;8?L4L615 E5EG59%U'Q3J .=\JUHCLGRE;4CF>,
M;V(\43+UT5F3D)Z.;H.R331#\]*VG[@^##B95N/<DP!Y]C" 5KK!(OJ1ZEBQ
MN>-2 W9'">1[C,JWPEO#F,MCYX%.F>NOZXH[U5*W,3PN>(H P9]@CA1!MT@1
MN!0B(_R!SJ6J ;^K!/)^@\F[RAL2YK\SH@Q5? 4A?2 &PGZ+"=OC$(GWHR)"
M,\<' OQ0#23^!^J%A\<C$O+1C'+NTC<B0'MYE1Z(_4],['Z?KP#\];,[O]M3
M"YS]5A$@_G>O!?^!6Z0(W%/%9&)/Z0K _D ,I'Z*2=WC$)7WM4B@M#=2</Z#
M#WO/'A+J =,QX46/!G:;#N.ND$.1H^2<M391L?]+B0)#WQ)#D:.DH346&P;>
MSY3:Z4QP5/&KH<A1$M ZDPTSOQ:&F96[WW^;I>.?-TYW61^JH(Q1DDZ?*12V
MY9T&8=QCC!#??264,4JN&3*'PKEO_2C"AR*AR\]T%0)]((621LDQ@_904-\K
MEA*U&K&X?M XU$)AHV2688,HM!_)<IA85VS"B@>!]="]1:#L4=)*D%V4$ Q%
M+-5<;MTN[LO,'H^KODR"0WI-06@X4/+-%UA'"<IEDEA<>OWGA@G:"X6B4@Y^
M1H07@(#-5X+]^&78C^'84?+06INO!/O)R["?P+&CY**U-C&Q]^W'._4H%YXG
MT%XQ%#E*+EIC$1-X?J:Y4_=*/K-B/E0=]8,24/2(*6K8+.H.7YSD(7M[J83R
M1DQ7J\UA<KZ7VA#^'YO774E6ZZ',$1/7D-&F;S 6<7<W+7Q3B?8D4+XHN6JE
MG::1N@@K2OR[[ZX""A0E :TRTS#/&^F>?<RD"-Z//51!N:)DDCY330^\;AJQ
M]A[Z6U^#9["A#*O[-AK&^%TQ8WO0EVF:B?4]&L]3,8\4BA<E_0O::QCU2'(6
M,\/$](N]0E2,\&K.53HH9)1DSV^L8<+WBKI(4WO9G<_C<NL,U-UDXAMY0WHH
M<91<K]XH+OFAUAE5+^5?40H:!92T#VJZZ7&&QID=]E:]X_&C6S'C&64.5%#6
M*"F?SU3#;&_EHR)NG=YHE8XE]R\/J11"":,D> %K#4/>Z4<UWCT)%"Q*9E=I
M!VE,N%[&,R*FU#][H5H)!8R2Z87,H8V]4]#8.WWAV(N2\?E,(;$MYH;;(^IN
MS-F4^%>2!0N U]E@$@]8;7K]7K[DQZW@5FG>CX']4(W=(X4"QUDB&;+7-.HL
M888F19<&3! 1VY1JLZ[-DYW7EX(& &<-)= TRNW][Y3SST(NQ(@2+05-BDO]
MT!U^;Q%H%!"?(=;810G!-\DS2TGE$T&5YQCP2*'($9\=>NSAS+TL)C5OSCW%
MJSI"Q'TEH. 1'R*&S2+-3S/4]9D]TX_$D'4/0_Q]):#\$1\HALVBS9]7?7OB
MF<KP,_,](90VXE382FLHD$<IX?PJTTQ0'1Q;]H10R(AS7BNMH4"^3JF:VD'M
MDY(+,UNO[0S!]A2 0D><V1JTB@-_^7,=>;'^+4B^0@U^.P$B=J])K-=NQ+&;
M2%&<R45"E(=Z2 _ECKJPTF^T8?)W9D;5]O53WIFAS=M"DQ[J2T&C@)*N0DWC
MG%NW5O('3ZT[.BAOQ,2TRAC.FJELS%D\X)($K\MW9%"^B%EHA2T4O%=$/*EL
M;N+5O9(QI>[QB=X<;8"$"%@!-"2(^>F+4.#<+I!IZA83R?AI-+.F]5UF\C>7
MVOX%;QH$RT%#@[F($V <Z2I(_USH19.KU0.=4.6F*3S2I;FR#3V%+XH Q:'Q
M07VC$!A#19C.NP>^;NP&]V[:XAOWR[U_U6[Y'U!+ 0(4 Q0    ( + ^"5>_
ML>8E61H  (^D   -              "  0    !R861N971?.&LN:'1M4$L!
M A0#%     @ L#X)5][Z7C9D+   6>   !$              ( !A!H  ')A
M9&YE=%]E>#$P,#$N:'1M4$L! A0#%     @ L#X)5^MU10$030  +J$# !$
M             ( !%T<  ')A9&YE=%]E>#DY,#$N:'1M4$L! A0#%     @
ML#X)5[1C\1\K5@  #+$! !$              ( !5I0  ')A9&YE=%]E>#DY
M,#(N:'1M4$L! A0#%     @ L#X)5X@<QHLI P  I0L  !$
M ( !L.H  ')D;G0M,C R,S X,#0N>'-D4$L! A0#%     @ L#X)5RT:84O^
M"@  @(8  !4              ( !".X  ')D;G0M,C R,S X,#1?;&%B+GAM
M;%!+ 0(4 Q0    ( + ^"5<@JTJW5 <  -%7   5              "  3GY
M  !R9&YT+3(P,C,P.# T7W!R92YX;6Q02P4&      < !P"] 0  P  !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
